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Ireland
The first survey on drug use in the general population was carried 
out in Ireland in 2002/03. The survey was repeated in 2006/07, 
2010/11, and 2014/15.1 In 2018, the Health Research Board (HRB) 
in Ireland commissioned IPSOS MRBI to conduct the fifth Irish 
National Drug and Alcohol Survey (NDAS).2
The 2019/20 NDAS followed best practice guidelines 
recommended by the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA). The questionnaire, based on the 
European Model Questionnaire, was administered in face-to-face 
interviews with respondents aged 15 years and older. A sample 
comprising all households throughout the island of Ireland was 
randomly selected to participate; 
fieldwork began in February 
2019 and was completed in 
March 2020. Of the household 
members contacted, 5,762 
agreed to take part. The sample 
was weighted by gender, age, 
and region to ensure that it was 
representative of the general 
population. The main measures 
were lifetime use (ever used), 
last-year use (recent use), and 
last-month use (current use).
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In brief
The emergence of the phenomenon of new 
psychoactive substances (NPS) since the mid-
2000s marks a new phase in our millennia-
long relationship with mood or mind-altering 
substances. Until the 19th century, most 
psychoactive substances were consumed 
by eating or drinking crude plant material. 
Developments in organic chemistry in the 
19th century allowed scientists and clinicians 
to develop more potent forms of the active 
ingredients extracted from plants and to 
deliver medicines more efficiently through 
technologies like the hypodermic needle. 
Eventually, thousands of new medicines with 
psychoactive properties were synthesised, only 
a fraction of which were used by clinicians. 
Inevitably, many of the new substances 
developed for research or experimental 
purposes came to be used in non-medical ways 
due to lax regulation and curiosity driven by 
sociocultural changes.
Synthesis was not confined to research settings 
and drugs with no medical application, such 
as LSD, ketamine, PCP, and MDMA, emerged 
through the work of hobbyists or criminal 
organisations. From the 1960s, these substances 
found their way onto the illegal drug market 
alongside medicines diverted from clinical 
use. However, in the mid-2000s, the quantity, 
type, and availability of these novel substances 
increased dramatically as the internet provided 
both the scientific information required to 
modify existing compounds and a means to 
facilitate distribution. Most novel substances 
serve as a short-term replacement for the 
more established drugs and are quickly 
replaced by newly synthesised products as 
their predecessors are controlled or fall out of 
favour. There is frequently a danger from very 
high potency and from the susceptibility of 
inexperienced users.
Legal classification of NPS is the first step in the 
policy response to the problem. From early on in 
their emergence on drug markets, international 
organisations have agreed to describe them as 
substances not controlled under the United 
Nations Drug Control Conventions, the basis 
on which most countries establish their drug 
control legislation. The volume of new drugs and 
the frequency of novel syntheses have made 
legislative responses difficult, with considerable 
variety in the approaches taken by national 
governments. The scientific response, in 
contrast, has been highly coordinated, at least 
in the European Union (EU). Monitoring bodies, 
laboratories, and health experts have created 
an integrated system of early warning systems 
across the EU, coordinating the work of national 
networks and building an efficient process of 
identification of substances likely to cause harm, 
adverse event reporting, and advice for both 
health services and regulatory authorities.
The rapid development of Covid-19 vaccines 
in 2020 was one of the most remarkable 
achievements in scientific history. The capacity 
and willingness of scientists to work together 
across national boundaries, a capacity often 
not displayed by governments, was essential 
to the rapid development and deployment of 
vaccines. The threat of new drugs to public 
health is, of course, far smaller than that of a 
pandemic. We still need to prepare for a rapidly 
changing situation in which a highly efficient and 
productive drug manufacture and distribution 
system can quickly supply new markets that 
may emerge over the coming years. While there 
is much work to be done in early warning, the 
knowledge infrastructure needed to respond to 
this danger to public health is in place. Europe’s 
early warning system is an outstanding example 
of scientific rigour, international cooperation, 
and refined communication, and provides 










   











21 prevalence, were cannabis (5.9%), ecstasy (2.2%), 
and cocaine (1.9%).
Cannabis use
Findings revealed that 24.4% of the population 
(15–64 years) had used cannabis at some point in 
their lives; 7.1% reported use in the year prior to 
the survey and 3.4% in the preceding month (see 
Figure 2).
Similar to earlier surveys, rates of cannabis 
use were greater among men than women: for 
lifetime use (29.5% vs 19.3%); last-year use (9.9% 
vs 4.4%); and last-month use (5% vs 2%). Since 
2002/03, lifetime, last-year and last-month rates 
of cannabis use among males have increased by 
32.9%, 37.5%, and 47%, respectively. Lifetime 
and last-year use of cannabis among females has 
also increased. However, last-month prevalence 
in women has remained relatively stable over 
time.
The prevalence of cannabis use was noticeably 
higher among young adults. However, lifetime 
and last-month rates were lower than those 
recorded in 2014/15, while last-year prevalence 
was unchanged at 13.8%.
National Drug and Alcohol 
Survey   continued
Use of any illegal drug
The proportion of respondents aged 15–64 
years who reported using any illicit drug in 
their lifetime has increased from almost 19% 
in 2002/03 to 27.1% in 2019/20 (see Figure 1). 
However, lifetime use has stabilised since the 
last survey. Similarly, last-year and last-month 
prevalence of any illegal drug use has remained 
stable since 2014/15; from 8.9% to 9% and 4.7% 
to 4.9%, respectively. Any illegal drug refers to 
the use of cannabis, ecstasy, cocaine powder, 
magic mushrooms, amphetamines, poppers, LSD, 
new psychoactive substances (NPS), solvents, 
crack, and heroin.
Illicit drug use was more prevalent in males and 
also greater among young adults, with 9.8% of 
persons aged 15–34 years having reported illegal 
drug use within the previous month (compared 
to 8.5% in 2014/15). Results from the 2019/20 
survey indicated that the most commonly used 












































































































































Figure 1: Lifetime, last-year, and last-month prevalence of any illicit drug use in Ireland,  
2002/03, 2006/07, 2010/11, 2014/15, and 2019/20
Source: NDAS, 2021
Note: Any illicit drug refers to the use of cannabis, ecstasy, cocaine powder, magic mushrooms, amphetamines, poppers, 
LSD, new psychoactive substances (NPS), solvents, crack, and heroin.
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Cocaine use
Lifetime cocaine use has increased when 
compared with 2014/15 rates (see Figure 3). The 
percentage of respondents aged 15–64 years 
who reported using cocaine (including crack) at 
some point in their lives increased from 7.8% to 
8.3%. As was observed in previous surveys, more 
men reported using cocaine in their lifetime 
compared with women (11.6% vs 5.1%).
Recent use of cocaine among 15–64-year-olds 
has increased from 1.1% in 2002/03 to 2.3% in 
2019/20, although cocaine use remained stable 
between 2006/07 and 2014/15. Since the 2014/15 
survey, recent cocaine use among males has 
increased from 2.6% to 3.5%, while use among 
females has increased from 0.5% to 1.2%. There 
were also noticeable increases in the use of 
recent and current use of cocaine among young 
adults; last-year prevalence has increased from 
2.9% in 2014/15 to 4.8% in 2019/20, while current 
use increased from 0.9% in 2014/15 to 1.5% in 
2019/20.
Ecstasy use
Ecstasy was found to be the second most 
commonly used illegal drug (after cannabis) in 
the year prior to the survey. With the exception 
of the 2010/11 survey, recent ecstasy use has 
increased at each survey; there was a significant 
decrease in 2010/11 (to 0.5%) but recent use 
increased to 2.1% in 2014/15 (see Figure 4).
Almost 14% of young adults (15–34 years) said 
they had tried ecstasy at least once in their 
lifetime, with 6.5% having used it within the last 
year (vs 4.4% in 2014/15) and 3.1% indicating 
current use (vs 2.1% in 2014/15).
New psychoactive substances use
Last-year prevalence of NPS use was included as 
a drug category for the first time in the 2010/11 
drug prevalence survey. Findings from the 
2014/15 survey demonstrated a reduction in the 
use of NPS in the Irish population among both 
genders.












































































































































Figure 2: Lifetime, last-year, and last-month prevalence of cannabis use in Ireland,  










   





















































































































































Figure 3: Lifetime, last-year, and last-month prevalence of cocaine use (including crack) in 
Ireland, 2002/03, 2006/07, 2010/11, 2014/15, and 2019/20
Source: NDAS, 2021













































































































































Figure 4: Lifetime, last-year, and last-month prevalence of ecstasy use in Ireland,  
2002/03, 2006/07, 2010/11, 2014/15, and 2019/20
Source: NDAS, 2021
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Findings from the 2019/20 NDAS show that the 
prevalence of recent NPS use remains very 
low in Ireland, at 0.8% among 15–64-year-
olds (compared with 3.5% in 2010/11). This 
perhaps highlights the continued impact of the 
Criminal Justice (Psychoactive Substances) Act 
2010, which made the sale, import, export, or 
advertisement of unregulated psychoactive 
substances for human consumption illegal. The 
Act also gave appropriate powers to An Garda 
Síochána and the Courts to intervene quickly to 
prevent trade in a non-criminal procedure via 
the use of prohibition and closure orders.
Conclusion
Although results from the 2019/20 NDAS suggest 
that there has been no change in the prevalence 
of any recent (last-year) illegal drug use in 
Ireland since 2014/15, there have been changes 
regarding the types of drugs used. Importantly, 
while there has been a small decrease in the 
prevalence of cannabis use, the use of cocaine 
and ecstasy has increased.
It should be noted that although opioids were 
included as a drug category in the 2019/20 drug 
prevalence survey, the prevalence of heroin use 
was low, as the NDAS is a general population 
survey. Thus, persons who do not normally reside 
in private households have not been included. 
A national 3-source capture-recapture (CRC) 
study to provide statistically valid estimates of 
the prevalence of opiate drug use in the national 
population was commissioned by the National 
Advisory Committee on Drugs and Alcohol and 
undertaken in 20013 and 2006.4 The three data 
sources used were the Central Treatment List (of 
clients on methadone), the Hospital In-Patient 
Enquiry (HIPE) scheme, and Garda PULSE data. A 
third study using the CRC method was published 
in 2017.5 In 2020, the HRB awarded a contract 
to the School of Public Health, University 
College Cork to conduct a fourth study on 
the prevalence of opioid use in Ireland for the 
years 2015–2019 and this research is due to be 
completed shortly.
Seán Millar
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In April 2021, the Participation framework: 
national framework for children and young 
people’s participation in decision-making 
was launched by the Department of Children, 
Equality, Disability, Integration and Youth 
(DCEDIY).1 The framework aims to support 
departments, agencies, and organisations to 
improve their practice in listening to children 
and young people and giving them a voice in 
decision-making.
Policy context
The goal of the National Strategy on Children 
and Youth People’s Participation in Decision-
Making 2015–20202 was to ensure that children 
and young people have a voice in their individual 
and collective everyday lives across the five 
national outcome areas set out in Better 
outcomes, brighter futures: the national policy 
framework for children and young people, 
2014–2020.3 These outcomes were for children 
to be active and healthy; to be achieving in 
all areas of learning and development; to 
be safe and protected from harm; to enjoy 
economic security and opportunity; and to be 
connected, respected, and contributing. One 
of the key fundamentals of the strategy was 
an acknowledgement that children and young 
people are not ‘beings in becoming’ but ‘citizens 
of today’ with the right to be respected and 
heard during childhood, their teenage years, 
and in their transition to adulthood (p. v).2 
The new framework is the latest in a series of 
developments to deliver on the strategy’s goal.
The strategy and framework are primarily aimed 
at children and young people under the age of 
18, but also embrace the voice of young people 
in the transition to adulthood up to the age of 24. 
Both focus on the everyday lives of children and 
young people and the places and spaces in which 
they are entitled to have a voice in decisions that 
affect their lives. They are guided and influenced 
by the United Nations Convention on the Rights 
of the Child (UNCRC); the European Union (EU) 
Charter of Fundamental Rights (for the strategy); 
the UN Convention on the Rights of Persons 
with Disabilities (for the framework), and relevant 
national legislation (see Appendix 1 of the 
framework).4,5,6,1
Identifying a need
Following the introduction of the strategy and 
the activities of organisations, such as Hub 
na nÓg and Comhairle na nÓg, an increasing 
number of statutory and non-statutory 
stakeholders sought support and guidance from 
DCEDIY on how best to meet their obligations 
in this area. They required support and training 
on how to effectively consult with children 
and young people and how to involve them in 
decision-making. The framework sets out to 
meet this need.
Framework vision
The vision of the framework is ‘participation 
with purpose’, which means involving both the 
purpose (or objective) of the organisation and 
the children and young people in the decision-
making. At its core, participation with purpose 
ensures ‘that when children and young people 
are involved in decision-making, their views are 
listened to, taken seriously and given due weight, 
with the intention that these views will influence 
the outcome or initiate change’ (p. 6).1
In addition to being a human right, the 
framework recognises that involving children 
and young people in decision-making results in 
more effective policies, services, programmes, 
facilities, learning approaches, clubs, cultural and 
sporting activities, and other initiatives.
Guidance
Children and young people’s participation in 
decision-making is defined by the UN Committee 
on the Rights of the Child as: 
…ongoing processes, which include 
information-sharing and dialogue between 
9
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children and adults based on mutual respect, 
and in which children can learn how their 
views and those of adults are taken into 
account and shape the outcome of such 
processes. (p. 3)4
In this context, the framework provides guidance 
for stakeholders on a wide range of topics in how 
best to carry out these processes. For example, 
guidance on involving children and young people 
in decision-making at different levels within 
organisations and descriptions of the various 
structures that can be used. It also deals with 
issues such as how to ensure the involvement of 
seldom-heard children and young people and 
how to follow up on their views and give them 
feedback. A large proportion of the report is 
taken up with examples of good practice in the 
field.
Checklists and feedback forms
The framework provides three checklists 
(planning, evaluation, and everyday spaces) and a 
series of feedback forms for children and young 
people. The authors argue that these provide 
a simple but structured way to guide decision-
makers in their use of the rights-based model 
and good practice principles, which are at the 
core of the framework (see Lundy model in 
Figure 1). They are tools that organisations can 
use to effectively plan, conduct, and evaluate 
their child and youth participation processes 
and initiatives. They also give children and young 
people a voice in decision-making in everyday 
spaces or settings.
Enabling factors
Four enabling factors that underpin the effective 
implementation of the framework are identified.  
Stakeholders need to ensure:
• Organisational buy-in
• Training and capacity building for decision-
makers
• Resources (financial, human, time)
• Monitoring and evaluation.
Next steps
The framework should be a valuable resource 
for those working in the sector. It is to be 
complemented by training and support from Hub 
na nÓg; a new National Participation Office; and 
ongoing Government commitment to Comhairle 
na nÓg, which works on the inclusion of young 
people in decision-making at local and national 
level.
Lucy Dillon
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Figure 1: Lundy rights-based model of 
participation
Source: Department of Children, Equality, Disability, 
Integration and Youth (2021), p. 15
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Facilitating young people   continued
Youth Justice 
Strategy 2021–2027
On 15 April 2021, Minister of State for Law 
Reform James Browne TD and Minister for 
Justice Helen McEntee TD launched a new Youth 
Justice Strategy 2021–2027.1,2 It is centred on a 
developmental framework that aims to target 
ongoing and emerging challenges in youth 
justice.2 A key strength of this strategy is that its 
development was informed by an expert steering 
group representing key stakeholders, such as the 
Department of Justice; Department of Health; 
Department of Children, Equality, Disability, 
Integration and Youth; the Probation Service; An 
Garda Síochána; Oberstown Children Detention 
Campus; Department of Education and Skills; 
Tusla; University College Cork (UCC); University 
of Limerick; Solas; Children’s Rights Alliance; 
and Foróige. The steering group was assisted 
by experts, Dr Louise Forde and Dr Katharina 
Swirak, from the UCC Centre for Children’s 
Rights and Family Law, who provided content 
and guidance from a valuable evidence base.1
Focus of strategy
Guiding principles
The strategy is grounded on principles derived 
from international and national legal standards 
related to youth justice, such as the United 
Nations Convention on the Rights of the Child 
and the European Convention on Human 
Rights.3,4 In a separate document, Forde (2020) 
provides an overview of these standards and 
outlines some of the main principles that emerge 
from them.5
Purpose, context, and scope
By using a developmental framework, it is 
hoped that the strategy will result in meaningful 
collaborative stakeholder engagement and 
allow for flexibility to address challenges and 
developments as they arise. Hence, the strategy 
is a living document subject to review, where 
progress reports will be published annually.
Youth Justice Strategy
Figure 1 shows the main themes that the strategy 
aims to address. The details of each will be 
presented separately in the article.
Theme 1: Governance, monitoring and 
support
The strategy aims to deliver governance, 
monitoring, and support for policy 
implementation. The development of practice 
and programmes will be based on evidence. 
As shown in Table 1, several objectives were 
identified.
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Theme 2: Services for children and young 
people
The strategy aims to provide services to children 
and young people who come into contact 
with the criminal justice system or who are in 
situations that may result in offending behaviour 
in order to help them develop and stop offending 
behaviours. Table 2 outlines the main themes and 
objectives to be addressed.
Theme 3: Criminal justice system and 
processes
The strategy aims to implement criminal justice 
processes that help children and young people 
stay away from offending behaviour and adopt 
positive life choices, while at the same time 
ensuring that the rights of victims are upheld. 
Several objectives were identified, as outlined in 
Table 3.
Figure 1: Thematic objectives of the Youth 
Justice Strategy 2021–2027
Source: Youth Justice Strategy 2021–2027 (p. 10)1
Youth Justice Strategy 2021–2027 
continued
Theme Objective
Oversight structures 1.1  Oversight of youth justice policy and its implementation will be 
enhanced.
Oversight support 1.2  The research partnership on youth justice between the University of 
Limerick’s Research Evidence into Policy Programmes and Practice 
(REPPP) and the Department of Justice will be continued. It includes 
action research, engaging with delivery services, and monitoring 
progress.
National policies 1.3  Policy development and implementation will take full account of 
the situations resulting in offending behaviour in children and young 
people with the aim of policy programme and practice effectiveness.
Coordinated services 1.4  Effective systems will be developed that are aligned with the reform 
agenda in ‘Our Public Service 2020’.6 These need to be tailored to the 
needs of children and young people rather than agency obligations 
and funding.
Voices of children and  
young people
1.5  It will be ensured that programme and service planning, design, and 
operation consider the voices of children and young people.
Legislation 1.6  Statutory backing will be provided to enhance agency collaboration.
1.7  Legislation, such as the Children Act 2001, will be amended as 
necessary. This will be centred on finalising provisions to replace 
suspended sentences in young people under 18.
Table 1: Governance, monitoring and support objectives
1. Governance,  
Monitoring and Support
2. Services  













   













Training and frontline support 1.8  The capacity of practitioners working with young people will be 
enhanced by providing support and guidance and building on existing 
initiatives.
1.9  Training specific to the criminal justice system will be provided to 
practitioners. For example, Gardaí will be trained in ‘stop and search’ 
and other police powers; specialised training will be provided to legal 
professionals so that children and young people have access to a 
lawyer; the Probation Service will continue to use qualified probation 
officers to engage with young offenders.
Research and evidence 1.10 Communication and cooperation will be increased between agencies 
and researchers to make better use of data and research to inform 
youth justice policy.
Emerging issues 1.11  Policy responses and key actions targeting emerging challenges that 
influence youth justice policy will be based on evidence. This will be 
achieved through monitoring.





2.1  Oversight of youth justice policy and its implementation will focus on the needs 
of children and young people in situations with an increased likelihood to result in 
offending behaviour.
Education 2.2  The impact of not engaging in education and leaving school early will be focused on, 
along with providing help to those who are vulnerable and moving in that direction. 
Garda Youth Diversion Projects will support schools where behaviour is likely to bring 
children into contact with the law.
2.3  Ways to increase the range of positive leisure time and developmental pursuits in at-risk 
young people will be assessed.
Diversion 2.4  Garda diversion policies, practices, and policing will be reinforced to consider the best 
interests of children and young people, while at the same time considering factors such 
as age, maturity, being disadvantaged, and diversity.
2.5  Existing operational procedures for diversion will be strengthened to reduce delays and 
ensure that the decision-making process is fully informed and transparent.
2.6  The Garda Diversion Programme will be developed flexibly in line with policing and 
community-based services development.
2.7  Criminal cases that involve children and young people will be fully dealt with regardless 
of diversion programme admission or not.
2.8  At-risk young people will be identified and supported early. This will include providing 
family supports where needed.
2.9  The existing 105 Garda Youth Diversion Projects network will be strengthened to provide 
more early intervention and family support.
2.10  Practices used in youth diversion projects will be developed and disseminated.
Table 2: Services for children and young people objectives
Youth Justice Strategy 2021–2027   continued
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Detention 2.11  The service needs, accommodation, and operational requirements at Oberstown will be 
examined with the aim of determining future demands.
2.12  National policies on children in detention and in State care as outlined in Better 
Outcomes, Brighter Futures7 will be aligned with new frameworks.
2.13  Specific protocols for management and care of detained offenders aged between 18 
and 24 years will be developed.
Post-
detention
2.14  It will be ensured that services that engage in reintegrating children into the community 
will be appropriate and effective.
2.15 There will be enhanced services for young people aged 18 to 24 years who are released 
from prison.
Source: Youth Justice Strategy 2021–2027.1
Youth Justice Strategy 2021–2027   continued 
Theme Objective
Criminal justice system 
and processes 
• Bail supervision will be extended to ensure that it is available to all young 
people, especially those more susceptible to criminal behaviour and hard to 
reach.
• Facilities and procedures in Garda Stations and the Courts will be reviewed to 
ensure they are in line with Part 6 and Part 7 of the Children Act 2001.
• Specialised representation and appropriate information will be provided to  
help young people navigate the Courts process.
• Processing children and young people will be prioritised to reduce delays.
• Opportunities to help children and young people via supervision will be 
increased in the community.
Table 3: Criminal justice system and processes objectives
Source: Youth Justice Strategy 2021–2027.1
Conclusion
In launching the strategy, Minister Browne 
believes that it will address key ongoing 
challenges of youth crime as well as new and 
emerging issues in the youth justice area.
This strategy will respond collaboratively 
to the situation of vulnerable children and 
young people, with a strong focus on diverting 
them away from offending, prevention and 
early intervention. I can’t stress enough 
the importance of bringing all the relevant 
agencies and programmes together, and of 
supporting schools, to ensure that we provide 
a holistic, ‘wraparound’ response to the needs 
of children and young people at risk. (p. 2)2
The strategy was welcomed by Fíona Ní 
Chinnéide, executive director of the Irish Penal 
Reform Trust. She noted that the strategy is an 
opportunity to transform the lives and futures 
of disadvantaged children and young people in 
Ireland, with the emphasis on moving away from 
the formal justice system towards diversion as 
‘of paramount importance’ (p. 1).8 She further 
acknowledged the importance of ensuring 
that the child-centred aims of the strategy are 
achieved with resources and wider social policy 
measures.
Ciara H Guiney
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Youth Justice Strategy 2021–2027  
continued
A long-brewing 
crisis: the historical 
antecedents of major 
alcohol policy in 
Ireland
Introduction
The Public Health (Alcohol) Act 2018 in Ireland 
has been praised as a world-leading package 
of alcohol policy reforms. The path to alcohol 
policy change in Ireland was long and winding as 
well as politically perilous. Using policy feedback 
theory (PFT), a 2021 report investigated the 
political consequences of accumulating alcohol-
related health and social harms for processes 
from the earlier phases of the policymaking 
process (prior to 2009).1
Between 1987 and 2006, alcohol intake in Ireland 
increased from 9.8 to 13.4 litres of pure alcohol 
per capita, due in part to the Celtic Tiger period, 
where greater disposable income and relatively 
stable rates of alcohol taxation contributed to 
easier affordability of alcohol. Following the 
2008–2009 financial crisis, alcohol consumption 
began to decrease in Ireland but by international 
standards alcohol intake has remained high.
The health and social burden of alcohol 
consumption has been the subject of numerous 
studies in Ireland. This body of research helped 
persuade the Government that a new policy 
approach to alcohol was required. In 2013, led by 
the Department of Health, a series of measures 
were proposed to reduce both consumption and 
alcohol-related harms.
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Year Policy developments
1984 In a key mental health policy document released in 1984, The psychiatric services: planning for  
the future, the Government was urged to adopt an ‘interdepartmental’ approach to alcohol policy  
in recognition of alcohol’s cross-cutting nature. The report acknowledged that alcohol was a key 
source of several health and social problems in Ireland and called for an approach to alcohol  
rooted in public health and prevention.2 
1988 Rises in alcohol consumption and harms were driven by economic forces as disposable incomes 
increased. A range of policy decisions removed traditional barriers to alcohol and promoted 
greater consumption. These shifts began in the late 1980s and continued for the next 20 years. The 
Intoxicating Liquor Act 1988, for example, extended opening hours for pubs, while also enabling 
restaurants to have full liquor licences.
1996 In the late 1980s, prioritisation of health promotion in Ireland placed alcohol into sharper focus. 
In 1996, following several years of drafting and consultation, the Health Promotion Unit in the 
Department of Health released its report, National alcohol policy.3 The Government was urged to 
adopt numerous strategies for reducing alcohol consumption. Although the report was welcomed by 
the Government, no major policy changes were subsequently pursued.
2000 In 2000, a Commission on Liquor Licensing was appointed by the Minister for Justice to review 
Ireland’s alcohol licensing system. Early in the process, several stakeholders identified health concerns 
as central to any discussion about licensing. The commission deemed public health considerations as 
beyond its competence; however, it recommended a separate process be established.
The Intoxicating Liquor Act 1988 was updated in 2000, further liberalising licensing regulations, 
including extending pub opening hours and free movement of licences.
2002 The Strategic Task Force on Alcohol (STFA) was appointed in 2002 to investigate health-related 
aspects of licensing changes in Ireland.
2003 The Intoxicating Liquor Act 2003 was implemented to address some of the unintended consequences 
from policy reforms in 2000. Alcohol consumption was briefly tempered after the subsequent 
increase in alcohol taxes was imposed.
2004 STFA issued a report urging the Government to adopt legislation on alcohol marketing and 
promotions. Both the 1996 and 2004 reports were informed by a public health approach and 
supported with evidence of rising alcohol consumption as well as costs associated with alcohol harm.
2005 The Government decided against acting on STFA’s recommendations and instead announced several 
self-regulatory measures with the alcohol industry.
A long-brewing crisis   continued
Methods
The study traces the development of alcohol 
policy in Ireland over three decades, drawing on 
primary documents, secondary literature, and 
interviews with public health advocates, medical 
doctors, public health experts, and key decision-
makers.
Results
The study documents the struggle to have 
alcohol recognised as a public health issue in 
Ireland due to insufficient institutional authority 
and the accumulative effects of policy failures. 
These factors elevated the visibility of alcohol-
related harms for key stakeholders, helping spur 
greater demand for major policy change. The 
study identifies 2008/2009 as the key turning 
point. Table 1 provides a timeline of events, 
culminating in the enactment of the Public 
Health (Alcohol) Act in 2018.









   













2006 A parliamentary committee identified institutional weaknesses as a key reason that alcohol-related 
health harms had not been adequately addressed. The committee recommended that alcohol be 
included as part of the national drugs strategy’s (NDS) remit, as the NDS possessed a permanent 
policymaking structure. Yet this call to action again fell on deaf ears. 
The Restrictive Practices (Groceries) Order 1987 was abolished in 2006, allowing alcohol to be sold at 
below-cost selling.
2007 The Health Research Board (HRB) released its first major report on alcohol, identifying significant 
increases in health-related harms.
2008 During public consultations on the NDS, the Government could not avoid mounting public concern 
about inaction on alcohol. Public health advocates began to mobilise groups and stakeholders 
concerned about alcohol harms.
In January 2008, the Minister for Justice appointed the Government Alcohol Advisory Group to 
examine the growth of off-licences due to the mounting concern about the availability of alcohol, 
among other issues.
Several recommendations were proposed by the group and the Government enacted changes to the 
Intoxicating Liquor Act in 2008.
The new legislation included earlier closing time for off-licences and a plan for structural separation; 
however, the Government decided against implementing the latter.
2009 By 2009, there were clear signs that overall alcohol consumption was creating a significant health and 
social burden, as well as a broader recognition that the Government lacked adequate institutional 
structures for addressing the issue. There was a clear sense that doing nothing or leaving it to industry 
to self-regulate was not viable.
Key differences from the earlier period were the mounting public pressure and the mobilisation of key 
civil society groups not previously as engaged on alcohol-related matters.
In 2009, the Government created a steering group for the National Substance Misuse Strategy (NSMS) 
and tasked it with developing alcohol policy measures that could be integrated with the NDS. The 
creation of the steering group represented progress for public health advocates.
The HRB released a second report documenting increased social harms associated with alcohol 
consumption.
2010 In Budget 2010, the Government reduced excise duty on alcohol by 20%. Alcohol became increasingly 
affordable and accessible.
2012 The steering group’s report on the NSMS identified ‘price, availability and marketing’ as the drivers 
of alcohol consumption and urged the Government to adopt stricter alcohol policies. Many of the 
conclusions reached by the steering group were well established within public health circles. The 
willingness of the Government to listen to expert advice finally shifted. 
2013–
2014
Public health campaigners lobbied the Government to adopt the steering group’s recommendations.
The legislation was debated in Cabinet.
2015 The general heads of the Public Health (Alcohol) Bill were released. 
The Public Health (Alcohol) Bill was introduced in the Irish parliament.
2018 The Public Health (Alcohol) Act was passed.
Source: Adapted from Lesch and McCambridge (2021)1
A long-brewing crisis   continued
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Discussion and conclusions
The health and social impacts of the high 
consumption levels of alcohol in Ireland were 
largely overlooked by the Government for many 
years. In fact, many policy decisions resulted in 
increased alcohol consumption. Experts and 
subsequently civil society organisations and, 
to some extent, the general public could see 
evidence of alcohol-related harms on the rise. 
These forces placed significant pressure on the 
Government, leading first to the inclusion of 
alcohol under the NDS and eventually to the 
enactment of the Public Health (Alcohol) Act in 
2018.
In conclusion, an understanding of innovations 
in alcohol policy decision-making requires an 
appreciation of the historical context, including 
earlier policy failures.
Anne Doyle
1 Lesch M and McCambridge J (2021) A long-brewing 
crisis: the historical antecedents of major alcohol 
policy change in Ireland. Drug Alcohol Rev, Early 
online. https://www.drugsandalcohol.ie/34383/
2 Department of Health (1984) The psychiatric 
services – planning for the future. Report of a 
Study Group on the Development of the Psychiatric 
Services. Dublin: Stationery Office. Available online 
at: https://www.lenus.ie/handle/10147/45556
3 Department of Health (1996) National alcohol 
policy: Ireland. Dublin: Stationery Office.  
https://www.drugsandalcohol.ie/5263/
A long-brewing crisis   continued
Waiting for the wave: 
political leadership, 
policy windows, and 
alcohol policy change 
in Ireland
Background
Alcohol consumption has long been a source 
of major health and social problems in Ireland. 
A combination of factors undermined previous 
attempts to address alcohol as a public health 
issue, including the considerable political and 
economic power wielded by the alcohol industry 
and the failure of the Government to develop a 
fully integrated approach across its departments 
and agencies.
Methods
Using the multiple streams approach (MSA), a 
2021 study focused on the period between 2008 
and 2018 to explore how these barriers were 
overcome, how the Public Health (Alcohol) Bill 
made its way onto the Government agenda, and 
how the legislation was subsequently formulated.1
Results
Policy context
The public health community and the alcohol 
industry formed two opposing coalitions and 
competed to influence the direction of alcohol 
policy. Public health actors have historically 
found it difficult to counter the alcohol industry’s 
influence within successive Irish Governments. 
Economic priorities have dominated public 
health issues in discussions over alcohol policy. 
However, since the mid-2000s, the public health 
community has steadily gained more influence, 
helping shift the debate over alcohol. Increased 
public attention to alcohol-related harms 
(problem stream), developments within the 
institutional location of policymaking (the policy 
stream), and the political pressure exerted by 
politicians and advocates (the political stream) 









   













Alcohol-related harms were highlighted by the 
Health Research Board (HRB) and provided the 
Government with data to validate the claims 
being made and enabled advocates to link 
alcohol-related harms to broader problems 
with the health system, thereby mainstreaming 
alcohol as a health policy issue. Concerns about 
the health service in Ireland had become a ‘hot 
political issue’1 and the hospital trolley crisis of 
the late 2000s had generated a key opportunity 
for those advocating a public health approach to 
alcohol.
Pressure on the Government mounted following 
explicit links made between the HRB research 
and the fiscal pressures on the health system 
coupled with increasing public dissatisfaction.
The policy stream
When the Government decided to integrate 
alcohol and drugs into a combined National 
Substance Misuse Strategy (NSMS), it established 
a steering group with Dr Tony Holohan, the chief 
medical officer (CMO), as co-chair in 2008. Its 
task was to specify measures that could ‘tackle 
the harm caused to individuals and society by 
alcohol use and misuse’.2
The steering group report of 2012 recognised 
alcohol as a major societal problem and argued 
that the Government must take action and 
identified ‘price, availability and marketing’ as the 
key drivers of alcohol consumption.2 The report 
included key international research, stressing 
that a reduction in overall drinking was needed 
for harms to be reduced across society because 
they were so closely related at a population level.
The steering group’s comprehensive review 
of the international and national evidence, 
its broad membership, and its concrete set 
of policy recommendations set it apart from 
earlier institutional processes. The CMO used his 
institutional position to ensure that the Minister 
for Health gave proper consideration to the 
report. Furthermore, research carried out by the 
HRB confirmed public support for the steering 
group’s key policy recommendations.
The political stream
Between the appointment of the steering group 
and the release of its recommendations in 2012, 
the political landscape had shifted profoundly 
with implications for the development of 
alcohol policy. Several Government ministers 
wanted to act on the recommendations of the 
steering group but there was pushback within 
the coalition parties (Fine Gael and the Labour 
Party), particularly around the proposed plan 
to ban the alcohol industry from any sports 
sponsorship. During 2013, conflicts between 
the health ministers and their colleagues 
prominently included Leo Varadkar TD, the 
Minister for Transport, Tourism and Sport. Key 
sporting organisations lobbied Varadkar, who had 
maintained that there was insufficient evidence 
that marketing or sponsorship restrictions would 
reduce under-age drinking. In autumn 2013, the 
Cabinet dropped the sports sponsorship ban 
from the proposed Bill. Industry lobbying and 
Varadkar’s opposition were identified as key 
influences on that decision.
In October 2013, the Government released its 
alcohol strategy proposals. The legislation would 
comprise four main pillars: (1) minimum unit 
pricing; (2) the structural separation of alcohol 
from other products in shops; (3) restrictions 
on alcohol advertising and marketing; and (4) 
health information on alcohol products and 
marketing. The plan represented the first time 
the Government addressed alcohol as a public 
health issue.
Despite the backing of the Government, 
the alcohol legislation was slow to progress. 
However, a major Cabinet shuffle in 2014 saw 
Varadkar installed as the new Minister for Health. 
Notwithstanding activities in his earlier ministerial 
brief, Varadkar enthusiastically took up the 
legislation and his attention to alcohol harms and 
the potential role of population-level measures 
in curbing these harms dramatically shifted in 
his new position. Advocates described the-then 
Minister for Health’s medical background as 
conducive for policy learning.
Waiting for the wave   continued
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The opening of the policy window
In 2015, the Government published the Public 
Health (Alcohol) Bill. The general election in 
February 2016 saw Fine Gael retaining power 
and the new government announced in its 
Programme for Government a commitment to 
enact the Bill. Structural separation became 
a key target for industry lobbying. Retail trade 
associations claimed that the new regulations 
would burden small businesses. Fine Gael 
senators threatened to vote against the Bill if 
the Government failed to amend the structural 
separation provision.
The alcohol industry’s efforts to build a broader 
coalition of opponents to the structural 
separation was successful in slowing down the 
legislative process.
However, broader political shifts prevented the 
alcohol Bill from languishing in the upper house. 
In June 2017, Varadkar was appointed both 
leader of Fine Gael and Taoiseach and Simon 
Harris TD (Fine Gael) as Minister for Health, who 
was instructed to progress the Bill as soon as 
possible.
One former policy advisor explained:
Back in 2014 [Varadkar] could have stalled 
[the Bill], he could have put the brakes on it 
but … he did the opposite … When he [later] 
became the leader of the country … he made 
it one of his priorities … Once he did that, it 
was game, set and match.1
Along with political leadership backing the Bill’s 
enactment, between 2016 and 2018, Alcohol 
Health Alliance Ireland waged a sophisticated 
campaign to advance the legislation. It was 
chaired by Prof Frank Murray, a highly respected 
liver specialist whose political astuteness 
and calm and effective communication skills 
commanded respect. This constellation of forces 
exerted enormous pressure in forming the wave 
that washed through the political system.
In October 2018, after nearly three years of 
debate and more than six years since the 
steering group’s report, the Irish parliament 
passed the Public Health (Alcohol) Bill.
Discussion
Previous observations have identified a lack 
of political leadership as a key impediment to 
legislative action. In this more recent period, 
advocates have been better organised and the 
Department of Health has benefited from a 
string of strong and highly capable ministers keen 
to develop the application of the public health 
approach to alcohol-related harms in Ireland. 
Across interviews and other key documents, 
Leo Varadkar, Tony Holohan, and Frank Murray 
emerged as the central players.
Anne Doyle
1 Lesch M and McCambridge J (2021) Waiting for 
the wave: political leadership, policy windows, and 
alcohol policy change in Ireland. Soc Sci Med, 282: 
114116. https://www.drugsandalcohol.ie/34443/
2 Department of Health (2012) Steering group report 
on a National Substance Misuse Strategy. Dublin: 
Department of Health.  
https://www.drugsandalcohol.ie/16908









   













Trends in drug 
poisoning deaths, 





Drug poisoning (overdose) deaths are a leading 
cause of avoidable death with rates increasing 
globally. According to the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA), 
the mortality rate due to drug poisoning in 
the European Union in 2019 is estimated at 
14.8 deaths per million population aged 15–64 
years, with over three-quarters (77%) of these 
deaths among men.1 Consequently, as drug 
poisoning deaths are dominated by men, 
specific circumstances associated with drug 
poisoning deaths among women may be masked 
by combining trends for men and women. A 
2021 publication examined differences by sex in 
the rates of overall drug poisoning deaths and 
deaths involving specific drugs implicated in drug 
poisoning deaths in Ireland between 2004 and 
2017.2
Methods
Data for this study were extracted from the 
National Drug-Related Deaths Index (NDRDI) 
and the Health Service Executive’s Primary Care 
Reimbursement Service (PCRS). The NDRDI’s 
definition of a poisoning death is a death 
directly due to the toxic effect of one or more 
substances on the body. Joinpoint Regression 
Program was used to examine any changes in 
trends in age-standardised rates (ASR) from 
2004 to 2017, expressed as annual percentage 
changes, with a summary of the overall trend 
expressed as an average annual percentage 
change (AAPC). The relationship between the 
ASR of drug poisoning deaths and prescription 
data for benzodiazepines and antidepressants 
was examined using linear regression. Analyses 
were stratified by sex.
Results
There has been an increase in the ASR of drug 
poisoning deaths in Ireland, from 6.86 per 
100,000 in 2004 to 8.08 per 100,000 in 2017. This 
increase is mainly driven by deaths among men. 
For men, drug poisoning deaths involving cocaine 
(AAPC 7.7% [95% CI: 2.2–13.6]); benzodiazepines 
(AAPC 7.2% [95% CI: 2.9–11.6]); antidepressants 
(AAPC 6.1% [95% CI: 2.4–10.0]); and prescription 
opioids (AAPC 3.5% [95% CI: 1.6–5.5]) increased 
significantly between 2004 and 2017.
For women, drug poisoning deaths involving 
antidepressants (AAPC 4.2% [95% CI: 0.2–8.3]); 
benzodiazepines (AAPC 3.3% [95% CI: 0.1–6.5]); 
and prescription opioids (AAPC 3.0% [95% CI: 
0.7–5.3]) increased significantly between 2004 
and 2017, with a significant increase in drug 
poisoning deaths involving cocaine (albeit from 
a low baseline number of deaths), observed in 
the latter part (2011–2017) of the study period. 
While the ASR of drug poisoning deaths involving 
alcohol decreased among women (AAPC –4.0% 
[95% CI: –5.8 to –2.1]), there was no significant 
change observed among men.
A significant increase in two or more central 
nervous system (CNS) depressant drugs involved 
in drug poisoning deaths is reported among both 
men (AAPC 5.6% [95% CI: 2.4–8.8]) and women 
(AAPC 4.0% [95% CI: 1.1–6.9]).
Conclusions
The authors conclude that there was an increase 
in overall drug poisoning deaths in Ireland 
from 2004 to 2017. The increasing trend of two 
or more CNS depressant drugs implicated in 
drug poisoning deaths, especially the more 
recent significant increase among women, is of 
concern. The findings from this study highlight 
the need for an increased understanding 
among prescribers, people who use drugs, and 
policymakers of the physiological differences 
between men and women, how this affects drug 
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activity in the body, and the associated risks with 
consumption of multiple CNS depressant drugs.
A significant decrease in drug poisoning deaths 
involving alcohol was reported for women. 
However, no significant change was reported for 
deaths involving alcohol among men. The authors 
highlight that alcohol is a CNS depressant and 
suggest that prescribers should assess for and 
advise on alcohol use when prescribing CNS 
depressant drugs.
Benzodiazepines were the most common 
drug group in deaths involving two or more 
CNS depressants. The decreasing rate of 
benzodiazepines dispensed through the PCRS 
appears to correspond with the introduction 
of stricter prescribing regulations. Given the 
increased availability of illicit benzodiazepines,3 
this change in prescribing regulations may have 
partially resulted in an increased use of high-
potent illicit benzodiazepines. The authors 
state that advocates for people who use drugs 
should be consulted on and contribute to policy 
decisions around drug use. In addition, increased 
focus on treatment provision for misuse 
of benzodiazepines should be considered. 
The authors suggest that harm reduction 
initiatives, along with treatment interventions, 
which include pharmaceutical combined with 
psychosocial assistance, need to focus on the 
range of problematic drugs. Furthermore, 
reducing stigma associated with drug use and 
drug poisoning deaths, aligned with actions to 
target economic deprivation, are required.
Ena Lynn
1 European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) (2021) European drug report 
2021: trends and developments. Luxembourg: 
Publications Office of the European Union. Available 
online at:  
https://www.emcdda.europa.eu/edr2021_en
2 Lynn E, Cousins G, Lyons S and Bennett KE (2021) 
Trends in drug poisoning deaths, by sex, in Ireland: a 
repeated cross-sectional study from 2004 to 2017. 
BMJ Open, 11(9): e048000.  
https://www.drugsandalcohol.ie/34812/
3 Duffin T, Keane M and Millar SR (2020) Street 
tablet use in Ireland: a Trendspotter study on use, 
markets, and harms. Dublin: Ana Liffey Drug Project. 
https://www.drugsandalcohol.ie/31872/
Trends in drug poisoning deaths, 
by sex, in Ireland   continued
Relationships 
between cannabis 
and recent use of 
stimulant drugs
Background and methods
Individuals who use cannabis are more likely 
to use other illicit substances, with several 
epidemiological studies showing that the use 
of cannabis is significantly related to the use of 
‘harder’ illegal drugs, including stimulants such 
as cocaine and ecstasy.1 Increasingly, people 
entering addiction treatment are presenting 
with polysubstance use.2 Consequently, further 
research on the relationships between cannabis 
and stimulant use is needed to guide future 
regulation systems, to inform both clinical and 
public health practice, and to assess drug policy. 
This is particularly relevant in Ireland in 2021, 
given the rise in treatment cases presenting for 
cannabis use disorder (CUD) and cocaine use, as 
well as increases in the use of ecstasy observed 
among the general population.3
A 2021 Irish study4 determined the relationships 
between patterns of cannabis use and recent 
stimulant use, drawing on data from two large 
nationally representative surveys. The study 
also explored how frequency of cannabis use 
relates to stimulant use and whether subjects 
with a CUD – defined as cannabis abuse or 









   












of cocaine or ecstasy. In this research, published 
in the journal PLoS One, data were analysed 
from Ireland’s 2010/11 and 2014/15 National Drug 
Prevalence Surveys, which recruited 5,134 and 
7,005 individuals, respectively, aged 15 years or 
more, living in private households. Multivariable 
logistic regression analysis was used to examine 
the associations between patterns of cannabis 
use and recent stimulant use.
Results
Among survey participants who had used 
cannabis in the last month, 17.9% reported 
recent cocaine use, while almost one-quarter 
(23.6%) reported recent ecstasy use. There 
was a significant linear relationship between 
patterns of cannabis use and recent use of 
cocaine, ecstasy, or any stimulants, with last-
month cannabis users displaying greater odds 
(OR=12.03, 95% CI: 8.15–17.78) of having recent 
stimulant use compared with last year (OR=4.48, 
95% CI: 2.91–6.91) and former (reference) 
cannabis users. Greater frequency of cannabis 
use in the last 30 days was also significantly 
related to the use of stimulants. In addition, 
results demonstrated an association between 
CUD and recent use of cocaine or ecstasy 
(OR=2.28, 95% CI: 1.55–3.35).
Conclusions
The authors noted that relationships between 
recent and current use of cannabis and the use 
of cocaine or ecstasy were noticeably strong. As 
the use of cannabis with stimulants may increase 
the risk of negative health consequences, 
they suggest that education in community and 
medical settings about polydrug use and its 
increased risks may be warranted.
Seán Millar
1 Kandel DB, Yamaguchi K and Klein LC (2006) Testing 
the gateway hypothesis. Addiction, 101(4): 470–472.
2 Health Research Board (2018) Focal Point Ireland: 
national report for 2017 – treatment. Dublin: Health 
Research Board.  
https://www.drugsandalcohol.ie/30589/
3 Mongan D, Millar SR and Galvin B (2021) The 2019–20 
Irish National Drug and Alcohol Survey: main 
findings. Dublin: Health Research Board.  
https://www.drugsandalcohol.ie/34287/
4 Millar SR, Mongan D, O’Dwyer C, Smyth BP, Perry IJ 
and Galvin B (2021) Relationships between patterns 
of cannabis use, abuse and dependence and recent 
stimulant use: evidence from two national surveys in 
Ireland. PLoS ONE, 16(8): e0255745.  
https://www.drugsandalcohol.ie/34684/ 
Relationships between cannabis 
and recent use of stimulant 
drugs   continued
Age at first substance 
use, persistence of 
cannabis use, and 
cannabis use disorder 
in Ireland
Background and methods
There is ongoing debate regarding the 
relationships between early onset substance 
use and later use of other drugs. The common 
liability model states that a combination of 
risk factors places some people at increased 
risk of both early initiation and of subsequent 
progression to more serious and sustained 
drug abuse.1 Numerous studies have examined 
relationships between early onset drinking, 
tobacco, and cannabis use with later drug use. 
However, this research has tended to focus on a 
narrow 12–25-year-age range. In addition, fewer 
studies have explored factors associated with 
progression to ongoing, heavier, and problematic 
cannabis use among lifetime cannabis users. It 
is also unclear whether associations between 
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younger age at substance use onset and 
cannabis use patterns are independent of 
other influential factors that may constitute an 
underlying vulnerability for heavier substance 
use and substance use disorders.
A 2021 Irish study2 determined the relationships 
between age at first use of alcohol, tobacco, 
and cannabis and the patterns of cannabis use, 
frequency of use, and whether age of substance 
use onset is related to having a cannabis use 
disorder (CUD). In this research, published in the 
journal BMC Public Health, data were analysed 
from Ireland’s 2010/11 and 2014/15 National Drug 
Prevalence Surveys, which recruited 5,134 and 
7,005 individuals, respectively, aged 15 years or 
more, living in private households. Multinomial, 
linear, and binary logistic regression analyses 
were used to determine the relationships 
between age of substance use onset and 
patterns of cannabis use, frequency of use, and 
having a CUD.
Results
When compared with former users, the odds of 
being a current cannabis user were found to be 
reduced by 11% (OR=0.89; 95% CI: 0.83–0.95) 
and 4% (OR=0.96; 95% CI: 0.92–1.00) for each 
year of delayed alcohol and cannabis use onset, 
respectively. Among current users, significant 
inverse linear relationships were noted, with 
increasing age of first use of tobacco (β=–0.547; 
p<0.001) and cannabis (β=–0.634; p<0.001) 
being associated with a decreased frequency of 
cannabis use within the last 30 days. The odds of 
having a CUD were found to be reduced by 14% 
(OR=0.86; 95% CI: 0.78–0.94) and 11% (OR=0.89; 
95% CI: 0.82–0.98) for each year of delayed 
tobacco and cannabis use onset, respectively, 
in analyses which examined survey participants 
aged 15–34 years.
Conclusions
The authors discussed that planning models 
based on the needs of the population are 
important for the successful implementation 
of treatment services and to adequately plan 
these services requires an understanding of the 
population in need of treatment. Findings from 
this study suggest that, in Ireland, prevention 
initiatives should prioritise younger adult 
cannabis users with a pattern of very early onset 
tobacco or cannabis use.
Seán Millar
1 Van Leeuwen AP, Verhulst FC, Reijneveld SA, 
Vollebergh WAM, Ormel J and Huizink AC (2011) Can 
the gateway hypothesis, the common liability model 
and/or, the route of administration model predict 
initiation of cannabis use during adolescence? 
A survival analysis – the TRAILS study. J Adolesc 
Health, 48(1): 73–78.  
https://www.drugsandalcohol.ie/34674/ 
2 Millar SR, Mongan D, Smyth BP, Perry IJ and Galvin B 
(2021) Relationships between age at first substance 
use and persistence of cannabis use and cannabis 
use disorder. BMC Public Health, 21: 997.  
https://www.drugsandalcohol.ie/34249/ 
Age at first substance use, 
persistence of cannabis use, and 










   











21 Patterns of new 
psychoactive 
substance use among 
patients attending for 
opioid substitution 
treatment in Ireland
Until 2010, new psychoactive substances 
(NPS) could be bought legally in headshops in 
Ireland. However, recent finding from the Irish 
National Drug and Alcohol Survey 2019–201 
show that the prevalence of recent NPS use 
remains very low, at 0.8% among 15–64-year-
olds (compared with 3.5% in 2010/11). This 
perhaps highlights the continued impact of the 
Criminal Justice (Psychoactive Substances) Act 
2010, which made the sale, import, export, or 
advertisement of unregulated psychoactive 
substances for human consumption illegal. The 
Act also gave appropriate powers to An Garda 
Síochána and the Courts to intervene quickly 
to prevent trade in a non-criminal procedure 
via the use of prohibition and closure orders. 
Nevertheless, research on NPS use is lacking in 
Ireland, in particular among opioid-dependent 
patients, who are likely to be at increased risk of 
consumption.
A 2021 study2 investigated reasons for NPS use, 
administration, adverse effects, and consumption 
in the previous three months among patients 
attending an opium substitution clinic. In this 
research, published in the journal Heroin 
Addiction and Related Clinical Problems, data 
were collected on 213 subjects (69.5% male) 
by the National Drug Treatment Centre, Dublin 
through an interviewer-administrated survey.
It was found that a total of 133 (61.5%) 
participants had used NPS at least once and 14 
(6.6%) had used NPS in the last three months. 
Being older at the time of interview and when 
first consuming illicit substances were found to 
be inversely associated with NPS consumption. 
Ninety-three participants (71.5%) bought NPS 
for the first time from a headshop, 20.8% from 
a friend, and 6.9% from a dealer. After the 
closure of headshops, dealers were the most 
common source of NPS. Cathinones were the 
most commonly consumed NPS class. One-third 
of participants injected NPS, while almost one-
half of participants indicated having experienced 
no adverse effects, although paranoia did occur 
frequently.
The authors noted that only 11% of participants 
reported ongoing NPS use, implying that 
making the supply of NPS illegal reduced their 
consumption. They also suggest that as a high 
proportion of participants administered NPS 
intravenously, the closure of headshops is likely 
to have led to improved health outcomes among 
this group of patients.
Seán Millar
1 Mongan D, Millar SR and Galvin B (2021) The 2019–20 
Irish National Drug and Alcohol Survey: main 
findings. Dublin: Health Research Board.  
https://www.drugsandalcohol.ie/34287/
2 McCarron P, Smyth BP, Carroll G, et al. (2021) 
Patterns of new psychoactive substance use among 
opioid-dependent patients attending for opioid 
substitution treatment. Heroin Addict Relat Clin 
Probl, Early online.  
https://www.drugsandalcohol.ie/34176/
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Systematic review  
of media coverage  
on NPS in Ireland, 
2000–2010
In 2010, new psychoactive substances (NPS) 
were the subject of two pieces of legislation 
in Ireland.1,2 The first (enacted in May 2010) 
expanded the list of substances controlled under 
the Misuse of Drugs Acts 1977−1984 to include 
over 100 NPS.1 The second, the Criminal Justice 
(Psychoactive Substances) Act 2010 (enacted in 
August 2010), covered the sale of substances by 
virtue of their psychoactive properties. It was 
aimed at vendors of NPS and effectively made it 
an offence to sell a psychoactive substance.2 A 
2021 paper by Windle and Murphy reports on a 
systematic review of Irish media articles, entitled 
‘How a moral panic influenced the world’s first 
blanket ban on new psychoactive substances’.3
Methods
Previous studies have found positive impacts of 
the legislation for public health.4,5,6 Windle and 
Murphy’s study was not designed to evaluate 
the Acts or their impact on the NPS market, 
rather it set out to trace the ‘historical processes 
whereby attitudes towards heads shops shifted 
from one of toleration to the passing of this 
tough new law’ (p. 1). The authors carried out 
a qualitative and quantitative review of media 
coverage of headshops in Ireland published 
between 2000 and 2010 (n=338).
Findings
The authors argue that analysis of the media 
coverage of headshops over the period 
demonstrates that Ireland experienced a ‘moral 
panic’ about headshops, which at least in part 
led to the 2010 Act. Based on previous national 
and international research, they frame their 
findings around a moral panic theory. Four 
timeframes are identified:
• 2000–2007 (6 articles): Headshops first 
opened in Ireland in the early 2000s selling 
cannabis paraphernalia. They were only 
mentioned in the media sporadically and 
most of the articles published between 2004 
and 2007 viewed them as harmless. However, 
once they started to sell NPS in 2007 a ‘trickle 
of condemnation began’ (p. 3).3
• 2008 (19 articles): Coverage of headshops 
was again sporadic in 2008 and tended to 
focus on the NPS benzylpiperazine (BZP) 
and its scheduling as a controlled substance 
in early 2009. Discussion of the negative 
impact of NPS on young people’s health and 
wellbeing also began to be discussed.
• 2009 (27 articles): Media interest increased 
in 2009 but continued to be at a relatively 
low level. The language used to describe 
headshops was ‘relatively timid’, although 
isolated incidents of them being described 
as a threat by stakeholders occurred. This is 
what the authors describe as a ‘core feature 
of moral panic language’ (p. 4).
• 2010 (286 articles): 2010 was when the 
authors argue the moral panic ensued. 
Articles on headshops and their supply of NPS 
were numerous and appeared regularly across 
local and national newspapers. They attracted 
high-level political attention as well as that 
from other stakeholders, including medical 
experts. The authors argue that the language 
used in the articles about NPS became 
gradually more stringent and sensationalist 
during the year and were characterised by 
methods such as ‘panic messages’ that fed 
into a moral panic. Articles linked NPS to 
violent crime and reported that headshops 
were selling to vulnerable people, especially 
young people. The narrative identified NPS 
and the headshops as the ‘folk devils’, where 
young people were depicted as victims. The 
year 2010 also saw peaceful and more violent 
protests organised by a variety of people, 
including drug dealers. All of this culminated 
in the State response of the Criminal Justice 
(Psychoactive Substances) Act 2010.
Conclusion
The authors are keen to note that while they 
make the case that analysis of media coverage 
provides evidence of a moral panic in Ireland 
over the headshops, they are not arguing that the 









   












they perceive the closure of the headshops as 
having been inevitable, given the nature of drug 
policy in Ireland. However, they consider that the 
moral panic may have resulted in more stringent 
legislation being passed more quickly than may 
otherwise have been the case. 
Lucy Dillon
1 Misuse of Drugs (Amendment) Regulations 2010 (SI 
No. 200/2010). Available online at: 
http://www.irishstatutebook.ie/eli/2010/si/200/
made/en/print
2 Criminal Justice (Psychoactive Substances) Act 
2010. Available online at: 
http://www.irishstatutebook.ie/eli/2010/act/22/
enacted/en/html
3 Windle J and Murphy P (2021) How a moral panic 
influenced the world’s first blanket ban on new 
psychoactive substances. Drugs Educ Prev Pol, Early 
online. https://www.drugsandalcohol.ie/34014/
4 Previous articles in Drugnet Ireland have described 
the findings of studies which have shown how 
the legislation and consequent closure of the 
headshops were associated with a positive public 
health impact, for example: Dillon L (2017) Headshop 
legislation and changes in national addiction 
treatment data. Drugnet Ireland, 62 (Summer): 
13–14. https://www.drugsandalcohol.ie/27740/ 
5 Smyth BP, Lyons S and Cullen W (2017) Decline in 
new psychoactive substance use disorders following 
legislation targeting headshops: evidence from 
national addiction treatment data. Drug Alcohol 
Rev, 36(5): 609–617. http://www.drugsandalcohol.
ie/27172/ 
6 Smyth BP, Daly A, Elmusharaf K, McDonald C, Clarke 
M, Craig S, et al. (2020) Legislation targeting head 
shops selling new psychoactive substances and 
changes in drug-related psychiatric admissions: a 
national database study. Early Interv Psychiatry, 14(1): 
53–60. https://www.drugsandalcohol.ie/30436/ 
Media coverage on NPS in 
Ireland, 2000–2010   continued
PREVALENCE AND CURRENT SITUATION
Drug treatment in 
Ireland, 2014–2020
Published in July 2021, the latest National Drug 
Treatment Reporting System (NDTRS) report 
presents trends in treated problem drug use 
(excluding alcohol) for the seven-year period 
from 2014 to 2020.1,2
Key findings
Over the period, some 68,571 cases treated 
for problem drug use (excluding alcohol) were 
reported to the NDTRS.3 The number of treated 
cases recorded decreased from 9,890 in 2014 
to 9,702 in 2020 (see Table 1). Between 2019 and 
2020, the number of treated cases decreased by 
9%, from 10,664 cases to 9,702 cases.
The overall drop in the number of cases entering 
drug treatment in 2020 is in part the result 
of temporary service closures and measures 
introduced to comply with Covid-19 restrictions 
and does not necessarily indicate a real decline in 
demand for treatment.4,5
New cases (never previously treated) accounted 
for 38.2% of cases in 2014 and 39.1% in 2020. 
Previously treated cases accounted for 57.1% of 
cases in 2014 and 56.1% in 2020.
In 2020, the majority (70.2%) of cases were 
treated in outpatient facilities (as in previous 
years), while 12.3% of cases were treated in 
inpatient facilities, 9% in low-threshold services, 
7.8% in prisons, and 0.8% by general practitioners 
(see Table 2).6
Between 2019 and 2020, the number of cases 
treated in residential settings decreased by 24.3%, 
from 1,571 cases to 1,190 cases. The reduction in 
residential case numbers can in part be attributed 
to temporary closures and measures introduced 
to comply with Covid-19 restrictions.
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Main problem drug
Opioids (mainly heroin) remain the main problem 
drug reported over the period. As a proportion 
of all cases treated, opioids decreased year-
on-year from 50% in 2014 to 36.7% in 2020 (see 
Table 3).
Cocaine was the second most common main 
problem drug reported in 2020. The proportion 
of cases treated for cocaine as a main problem 
increased from 8.6% in 2014 to 27% in 2020.
Cannabis was the third most common main 
problem drug reported in 2020. The proportion 
of cases treated for cannabis as a main problem 
decreased from 27.6% in 2014 to 21.9% in 2020.
In 2020, cocaine (35.8%) replaced cannabis as 
the most common main problem drug among 
new entrants to treatment (see Table 3). Cocaine 
was followed by cannabis (35.2%) and opioids 
(14.5%). Among new cases, cocaine increased 
from 11.3% in 2014 to 35.8% in 2020.
Polydrug use
Over the period, the majority of cases (58%) 
reported polydrug use (i.e. problem use of more 
than one substance). The proportion of cases 
that reported polydrug use decreased from 
59.6% in 2014 to 53.4% in 2018, then increased to 
58.6% in 2020 (see Table 4).
2014 2015 2016 2017 2018 2019 2020
n % n % n % n % n % n % n %
All cases 9890 9892 9227 8922 10274 10664 9702








471 4.8 295 3.0 366 4.0 423 4.7 440 4.3 758 7.1 465 4.8
Table 1: Number of cases treated for drugs as a main problem, by treatment status,  
NDTRS 2014–2020
2014 2015 2016 2017 2018 2019 2020
n % n % n % n % n % n % n %
All cases 9890 9892 9227 8922 10274 10664 9702
Outpatient 6251 63.2 5818 58.8 5481 59.4 5610 62.9 6715 65.4 6946 65.1 6806 70.2
Inpatient* 1348 13.6 1779 18.0 1885 20.4 1757 19.7 1384 13.5 1571 14.7 1190 12.3
Low 
threshold 1190 12.0 1197 12.1 886 9.6 792 8.9 887 8.6 948 8.9 870 9.0
Prison 844 8.5 827 8.4 737 8.0 651 7.3 1082 10.5 848 8.0 754 7.8
General 
practitioner 257 2.6 271 2.7 238 2.6 112 1.3 206 2.0 351 3.3 82 0.8
Table 2: Number of cases treated for drugs as a main problem, by type of service provider,  
NDTRS 2014–2020
* Includes any service where the client stays overnight, e.g. inpatient detoxification, therapeutic communities, respite, and 
step-down.
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21 Drug treatment in Ireland, 2014–2020   continued
2014 2015 2016 2017 2018 2019 2020
n % n % n % n % n % n % n %
All cases 9890 9892 9227 8922 10274 10664 9702
Opioids 4948 50.0 4732 47.8 4341 47.0 4016 45.0 4349 42.3 4133 38.8 3559 36.7
Cocaine 853 8.6 1026 10.4 1138 12.3 1500 16.8 2254 21.9 2560 24.0 2619 27.0
Cannabis 2730 27.6 2786 28.2 2439 26.4 2200 24.7 2358 23.0 2502 23.5 2120 21.9
Benzodiazepines 953 9.6 873 8.8 897 9.7 868 9.7 999 9.7 1082 10.1 1097 11.3
Z-drugs* 155 1.6 154 1.6 103 1.1 82 0.9 48 0.5 72 0.7 72 0.7
Amphetamines 58 0.6 63 0.6 55 0.6 40 0.4 57 0.6 59 0.6 53 0.5
NPS 71 0.7 85 0.9 72 0.8 51 0.6 48 0.5 63 0.6 43 0.4
MDMA (ecstasy) 56 0.6 51 0.5 53 0.6 44 0.5 34 0.3 47 0.4 31 0.3
Volatile inhalants 15 0.2 15 0.2 11 0.1 6 0.1 10 0.1 6 0.1 6 0.1
Other 51 0.5 107 1.1 118 1.3 115 1.3 117 1.1 140 1.3 102 1.1
New cases 3776 3742 3526 3257 3962 3979 3796
Opioids 1036 27.4 971 25.9 950 26.9 809 24.8 719 18.1 676 17.0 550 14.5
Cocaine 425 11.3 513 13.7 568 16.1 748 23.0 1232 31.1 1258 31.6 1359 35.8
Cannabis 1696 44.9 1693 45.2 1452 41.2 1272 39.1 1505 38.0 1506 37.8 1338 35.2
Benzodiazepines 419 11.1 340 9.1 353 10.0 290 8.9 345 8.7 340 8.5 392 10.3
Z-drugs 58 1.5 46 1.2 41 1.2 22 0.7 17 0.4 24 0.6 27 0.7
Amphetamines 30 0.8 33 0.9 24 0.7 19 0.6 34 0.9 37 0.9 28 0.7
NPS 43 1.1 53 1.4 36 1.0 21 0.6 25 0.6 22 0.6 26 0.7
MDMA (ecstasy) 37 1.0 31 0.8 39 1.1 29 0.9 18 0.5 38 1.0 21 0.6
Volatile inhalants 6 0.2 6 0.2 8 0.2 ~ ~ 8 0.2 ~ ~ ~ ~
Other 26 0.7 56 1.5 55 1.6 42 1.3 59 1.5 73 1.8 52 1.4
Table 3: Main problem drug (excluding alcohol) reported in 30 days prior to treatment,  
NDTRS 2014–2020
Z-drugs are non-benzodiazepine hypnotic sedative drugs, e.g. zolpidem and zopiclone.
NPS: New psychoactive substances.
~ Cells with five cases or fewer.
2014 2015 2016 2017 2018 2019 2020
n % n % n % n % n % n % n %
All cases 9890 9892 9227 8922 10274 10664 9702
One drug 




5897 59.6 6020 60.9 5703 61.8 5106 57.2 5487 53.4 5861 55.0 5683 58.6
Table 4: Polydrug use in cases treated for drugs as a main problem, NDTRS 2014–2020
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In 2020, cannabis (39.5%) was the most common 
additional substance reported by cases with 
polydrug use, followed by cocaine (36.8%), 
benzodiazepines (36.5%), and alcohol (34.9%).
Risk behaviour
The proportion of all cases that had ever 
injected decreased from 35.7% in 2014 to 23.3% 
in 2020. Among cases that had ever injected, the 
proportion currently injecting (i.e. in the 30 days 
prior to treatment) decreased from 37% in 2014 
to 31.1% in 2020.
Sociodemographic characteristics
The following sociodemographic characteristics 
of the cases were noted:
• Three in every four cases reported over the 
period were male.
• The median age of cases when entering 
treatment increased from 29 years in 2014 to 
31 years in 2018 and has remained stable ever 
since.
• Under 18s accounted for 6.9% of cases in 
2020.
• Cases recorded as homeless increased in 
proportion from 8.5% in 2014 to 10.5% in 
2020.
• The proportion of cases with an Irish Traveller 
ethnicity was 3% in both 2014 and 2020.
• A large proportion of cases (59%) were 
unemployed in 2020, as in previous years.
• The proportion of cases in paid employment 
increased from 8.3% in 2014 to 16.2% in 2020.
Sociodemographic characteristics  
– cocaine as main problem
The following sociodemographic characteristics 
of cases with cocaine as a main problem were 
noted:
• Eight in 10 cases reported over the period 
were male.
• The proportion of female cases increased 
from 17.2% in 2014 to 20.8% in 2020.
• The median age of cases when entering 
treatment was the same in 2014 and 2020  
(30 years).
• Under 18s accounted for 2% of cocaine cases 
in 2014 and 1.7% in 2020.
• The proportion of cases in paid employment 
increased from 19.9% in 2014 to 30.2% in 2020.
• Cases with polydrug use decreased in 
proportion, from 70.2% in 2014 to 63.3% in 
2020.
• In 2020, the most common additional 
substances were alcohol (53.9%), cannabis 
(49.8%), and benzodiazepines (31.7%).
Cathy Kelleher
1 The NDTRS is the national epidemiological 
surveillance system that reports on treated problem 
drug and alcohol use in Ireland. Established in 1990, 
the NDTRS is maintained by the National Health 
Information Systems (NHIS) of the Health Research 
Board (HRB) on behalf of the Department of Health.
2 Kelleher C, Carew AM and Lyons S (2021) National 
Drug Treatment Reporting System: 2014–2020 drug 
treatment data. HRB StatLink Series 6. Dublin: Health 
Research Board.  
http://www.drugsandalcohol.ie/34162
3 The data reflect the number of entries into treatment 
in a calendar year, rather than the number of persons 
treated in that year.
4 The capacity and functionality of treatment services 
were impacted by Covid-19 restrictions. The NDTRS 
surveyed participating services to estimate the 
impact of the restrictions on treatment data for 2020 
(the response rate was 80%). Around 40% of services 
surveyed expressed some impact on their ability to 
provide returns, while around 50% expected some 
impact on numbers (unpublished data).
5 To comply with European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA) requirements 
and enable services to accurately reflect their 
activities in response to Covid-19 restrictions, the 
NDTRS added functionality to the LINK database to 
record treatment provided over the telephone or 
internet (teleworking).
6 Coverage of services was 71.1% for 2020. The number 
of services participating in the NDTRS varies annually, 
making small fluctuations in the numbers of cases 
difficult to interpret.
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21 Alcohol treatment in 
Ireland, 2014–2020
Published in July 2021, the latest National Drug 
Treatment Reporting System (NDTRS) report 
presents trends in treated problem alcohol use 
for the seven-year period from 2014 to 2020.1
Key findings
Over the period, some 51,205 cases treated 
for problem alcohol use were reported to the 
NDTRS. The number of treated cases recorded 
decreased from 7,760 in 2014 to 5,824 in 
2020 (see Table 1). Between 2019 and 2020, 
the number of treated cases decreased by 
22.8%, from 7,546 cases to 5,824 cases. The 
overall drop in the number of cases entering 
alcohol treatment in 2020 is in part the result 
of temporary service closures and measures 
introduced to comply with Covid-19 restrictions 
and does not necessarily indicate a real decline 
in demand for treatment.
New cases (those never previously treated) 
accounted for 48.6% of cases in 2014 and 42.8% 
in 2020. Previously treated cases accounted for 
49.1% of cases in 2014 and 54.4% in 2020.
In 2020, three in every five (60.2%) cases were 
treated in outpatient facilities, while 28.8% of 
cases were treated in inpatient facilities, 8% in 
low-threshold services, and 3% in prisons (see 
Table 2).
Between 2019 and 2020, the number of cases 
treated in residential settings decreased by 
40.1%, from 2,806 cases to 1,680 cases. The 
reduction in residential case numbers can in 
part be attributed to temporary closures and 
measures introduced to comply with Covid-19 
restrictions.
Focus on gender
The median age of female cases that entered 
treatment was 43 years compared with 40 
years for male cases. Among new female cases 
specifically, the median age entering treatment 
was 41 years. This compared with a median age 
of 38 years among new male cases that entered 
treatment. Among female cases, 32.6% were 
aged 50 years or over compared with 25.7% of 
male cases aged 50 years or over. Among those 
treated for alcohol, homelessness was more 
common for males (10.7%) than females (4.8%).
The proportion of female cases reporting 
problem use of other drugs in addition to alcohol 
was 17%. The most common additional drugs for 
females were cocaine and cannabis. Rates of 
benzodiazepines and opioid use were found to 
be more common among females than males. 
One in four male cases (26.9%) reported problem 
use of other drugs in addition to alcohol. The 
common additional drugs for male cases were 
cannabis and cocaine.
Polydrug use
In 2020, some 23.1% of cases treated for 
problem alcohol use reported problem use of 
more than one substance (polydrug use) (see 
Table 3).
In 2020, cannabis (54.9%) was the most 
common additional drug reported by cases 
with polydrug use, followed by cocaine (54.1%) 
and benzodiazepines (24.6%) (see Figure 1). The 
proportion of cases reporting cannabis use 
decreased from 63.2% in 2014 to 54.9% in 2020. 
Problem use of cocaine increased from 28.2% in 
2014 to 54.1% in 2020. The proportion of cases 
treated for benzodiazepines decreased from 
27.9% in 2014 to 21.8% in 2019, then increased to 
24.6% in 2020.
Figure 1: Most common additional drugs in 
cases treated for problem alcohol use, NDTRS 
2014–2020
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Level of problem alcohol use
In 2020, the median age at which cases 
commenced alcohol use was 16 years. Over 
the period, the majority (66.1%) were classified 
as alcohol dependent (by the healthcare 
professionals treating them). The proportion 
of new cases (those never previously treated 
for problem alcohol use) that were classified as 
alcohol dependent decreased from a peak of 
66.8% in 2017 to 57.2% in 2020.
Sociodemographic characteristics
The following sociodemographic characteristics 
of the cases were noted:
• The median age at which cases entered 
treatment has remained stable since 2015, at 
41 years.
• The proportion of cases aged 17 years or 
younger has decreased from 2.1% in 2014 to 
1.7% in 2020.
2014 2015 2016 2017 2018 2019 2020
n % n % n % n % n % n % n %
All cases 7760 7618 7643 7350 7464 7546 5824








181 2.3 117 1.5 182 2.4 198 2.7 529 7.1 850 11.3 164 2.8
Table 1: Number of cases treated for alcohol as a main problem, by treatment status,  
NDTRS 2014–2020
2014 2015 2016 2017 2018 2019 2020
n % n % n % n % n % n % n %
All cases 7760 7618 7643 7350 7464 7546 5824
Outpatient 4133 53.3 4018 52.7 4005 52.4 3894 53.0 4087 54.8 4093 54.2 3505 60.2
Inpatient* 2803 36.1 2916 38.3 2994 39.2 2949 40.1 2792 37.4 2806 37.2 1680 28.8
Low 
threshold 605 7.8 480 6.3 495 6.5 436 5.9 451 6.0 469 6.2 467 8.0
Prison 219 2.8 204 2.7 149 1.9 71 1.0 134 1.8 178 2.4 172 3.0
Table 2: Number of cases treated for alcohol as a main problem, by type of service provider, 
NDTRS 2014–2020
* Includes any service where the client stays overnight, e.g. inpatient detoxification, therapeutic communities, respite, and 
step-down.
2014 2015 2016 2017 2018 2019 2020
n % n % n % n % n % n % n %
All cases 7760 7618 7643 7350 7464 7546 5824
Alcohol 





1508 19.4 1422 18.7 1328 17.4 1452 19.8 1603 21.5 1570 20.8 1347 23.1
Table 3: Polydrug use in cases treated for problem alcohol use, NDTRS 2014–2020









   












• The majority of cases in 2020 were male 
(61.9%), similar to previous years.
• The proportion of cases recorded as 
homeless increased from 6.4% in 2014 to 8.5% 
in 2020.
• In 2020, some 2.1% of cases identified as Irish 
Traveller.2
• In 2020, some 21.2% of cases reported 
ceasing education (for the first time) before 
the age of 16 years.
• Just under one-half of reported cases were 
unemployed; this rate decreased over the 
reporting period from 56.4% in 2014 to 49.2% 
in 2020.
• In each year, rates of homelessness, ceasing 
education before age 16, and unemployment 
were higher among previously treated cases 
than among new cases.
• In 2020, some 17.4% (n=1015) of cases treated 
for alcohol were residing with children aged 17 
years or younger. The majority were females 
(57.4%, n=583), while males accounted for 
42.6% (n=432).
• A similar number of cases (17.6%, n=1027) 
treated for alcohol in 2020 had children aged 
17 years or younger who were not residing 
with them. Almost three-quarters of these 
cases (72.4%, n=744) were males, while one-
quarter were females (27.6%, n=283).
Derek O’Neill
1 O’Neill D, Carew AM and Lyons S (2021) National 
Drug Treatment Reporting System 2014–2020 
alcohol treatment data. HRB StatLink Series 7. 
Dublin: Health Research Board.  
https://www.drugsandalcohol.ie/34164
2 Based on the 2016 Census, the proportion of Irish 
Travellers in the general population is 0.7%  
(Central Statistics Office, 2019). Available online at: 
https://www.cso.ie/en/releasesandpublications/
ep/p-cp8iter/p8iter/p8e/
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The first Health Behaviour in School-aged 
Children (HBSC) study was conducted in Ireland 
in 1998 and has been repeated every four years 
ever since. In 2018, Ireland participated for the 
sixth time in the HBSC study. The survey included 
15,557 children drawn from third class in primary 
school through to fifth year in post-primary 
school; 255 primary and post-primary schools 
across Ireland participated. Data were collected 
on general health, smoking, use of alcohol and 
other substances, food and dietary behaviour, 
exercise and physical activity, self-care, injuries, 
bullying, and sexual health behaviours. The main 
results were published in 2021.1 This article 
describes the results pertaining to the use of 
cannabis reported in the main report and makes 
comparisons with previous HBSC surveys.
Cannabis use in the last 12 months
Overall, 8.5% of 10–17-year-olds said they 
had used cannabis in the last 12 months. The 
prevalence of cannabis use increased with age 
and a higher percentage of boys reported using 
cannabis compared with girls, a difference 
consistent across each age category (see Table 
1). Almost 22% of boys and 14% of girls aged 15–17 
years of age reported having used cannabis in 
the last year.
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Figure 1: Percentage of 10–17-year-olds who reported cannabis use in the last 12 months, overall 
and by gender from 1998 to 2018
Source: HBSC Ireland, 20211
Health Behaviour in School-aged Children Study, 2018   continued
Trends in cannabis use among Irish 
school-aged children, 1998–2018
Although a higher percentage of 10–17-year-olds 
indicated having used cannabis in the 2018 HBSC 
survey compared with 2014 (see Figure 1), there 
has been a steady decrease in the lifetime use 
of cannabis among school-aged children since 
1998, with a 35% reduction among boys and a 
22% reduction among girls. Overall, trends in 
prevalence since 2010 suggest that the use of 
cannabis has stabilised among 10–17-year-olds in 
Ireland.
Seán Millar
1 Gavin A, Költő A, Kelly C, Molcho M and Nic 
Gabhainn S (2021) Trends in health behaviours, 
health outcomes and contextual factors between 
1998–2018: findings from the Irish Health Behaviour 
in School-aged Children Study. Dublin: Department  
of Health and National University of Ireland Galway. 
https://www.drugsandalcohol.ie/33868/
Age group Boys (%) Girls (%)
10–11 years 0.6 0.0
12–14 years 2.6 2.2
15–17 years 21.9 13.9
Table 1: Percentage of 10–17-year-olds 
reporting cannabis use in the last year,  
by age group and gender, 2018









   











21 Seventh ESPAD 
survey report 
published
The European Schools Project on Alcohol and 
Other Drugs (ESPAD) has conducted surveys 
of school-going children every four years 
since 1995 using a standardised method and a 
common questionnaire. The seventh survey was 
undertaken in 35 European countries during 2019 
and collected information on alcohol, tobacco, 
and other substance use among 15–16-year-old 
students.
An important goal of the ESPAD survey is to 
monitor trends in alcohol consumption, tobacco, 
and other drug use among 15–16-year-olds 
and to compare trends between countries 
and groups of countries. It also provides an 
opportunity to observe changes in Irish trends 
over the six waves of the past 20 years. The 
rationale for the ESPAD surveys is that school 
students are easily accessible and at an age 
when the onset of substance use is likely to 
occur.
This article concentrates on findings from the 
survey conducted in Ireland in 2019, in which 
3,565 questionnaires were completed by young 
people from 50 randomly selected post-primary 
schools.1 Of these participants, 1,967 were born 
in 2003 and will be included in the international 
ESPAD dataset.
Alcohol use
Respondents were asked on how many occasions 
in their lifetime had they used alcohol. Over one-
quarter (27.4%) answered that they had never 
consumed an alcoholic beverage in their lifetime. 
Overall, 72.6% of students had drunk alcohol 
in their lifetime, with 17.6% having tried alcohol 
once or twice. Seventeen per cent had drunk 
alcohol on more than 20 occasions. Although the 
percentage of students who indicated lifetime 
use of alcohol was similar according to gender 
(72.7% males vs 72.4% females), male students 
were more likely to have tried alcohol 40 times 
or more (11.7%) than females (7.1%).
Almost one-half (40.8%) of students had drunk 
alcohol in the last 30 days and were considered 
to be current drinkers. Almost one-quarter 
(23.4%) reported drinking alcohol once or twice 
in the past 30 days, while only a small proportion 
Alcohol use in the past 30 days 2003 2007 2011 2015 2019
% % % % %
Males 71 57 48 35 42
Females 74 56 52 37 40
All subjects 73 56 50 36 41
Table 1: Alcohol use in the last 30 days among 15–16-year-olds in Ireland,  
ESPAD surveys 2003–2019
Source: ESPAD Ireland, 2020
30-day cigarette use 2003 2007 2011 2015 2019
% % % % %
Males 28 19 19 13 16
Females 37 27 23 13 13
All subjects 33 23 21 13 14
Table 2: Smoking in the last 30 days among 15–16-year-olds in Ireland, ESPAD surveys 2003–2019
Source: ESPAD Ireland, 2020
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of respondents had used alcohol 10 times or 
more (3.7%). More male (42.1%) than female 
(39.5%) students indicated current alcohol use. 
Although the findings suggest an increase in 
current alcohol use among students since 2015, 
overall, current alcohol use among students in 
Ireland has declined (see Table 1), with a 44% 
reduction over the past 16 years.
Respondents were asked if they had been drunk 
in the last 30 days. Sixteen per cent of students 
reported being drunk, while 12.8% reported 
being drunk more than once or twice during the 
past month. More females (17.1%) than males 
(15.1%) reported being drunk in the last month.
Cider (28.5%), beer (27.3%), and spirits (27.1%) 
were the most common types of alcohol 
consumed in the month prior to the survey. 
The least popular drinks were wine (8.3%) and 
alcopops (14.2%). Respondents were asked 
how difficult they thought it would be to obtain 
specific alcoholic beverages, with response 
categories ranging from ‘impossible’ to ‘very 
easy’. A majority of students believed that it 
would be ‘very easy’ or ‘fairly easy’ to obtain all 
beverage types examined; 67.7% gave this answer 
for cider and 71.1% for beer. Only 8.5% believed it 
would be impossible to obtain spirits compared 
with 58.8% who said it would be ‘fairly easy’ or 
‘very easy’ to access.
Smoking
Participants were asked on how many occasions 
had they smoked cigarettes during their lifetime. 
More than two-thirds (68.4%) of students reported 
that they had never smoked a cigarette and 
a further 11% had only smoked on one or two 
occasions. Just 7.2% of all students reported 
smoking on at least 40 occasions. Overall, almost 
one-third had ever smoked in their lifetime 
(31.6%).
When students were asked to consider how 
often they had smoked in the last 30 days, 85.6% 
reported that they had not smoked at all, while 
14.4% had smoked at least once. Seven per cent of 
students reported smoking less than one cigarette 
per week and a further 1.9% smoked less than 
one cigarette per day. Only 11 students reported 
smoking more than 20 cigarettes a day. There were 
significant differences in current smoking between 
male and female students, as more male students 
had reported smoking in the last 30 days (16.2%) 
than had female students (12.8%).
Seventh ESPAD survey report 
published   continued
Lifetime use 2003 2007 2011 2015 2019
% % % % %
Cannabis 39 20 18 19 19
Inhalants 18 15 9 10 10
Cocaine 3 4 3 2 3
Ecstasy 5 4 2 3 3
Tranquilisers (non-prescribed) 2 3 3 3 3
Magic mushrooms 4 4 2 2 3
LSD 2 3 2 2 3
Crack 2 4 2 1 2
Amphetamines 1 3 2 2 2
Heroin 1 1 1 0.4 1
Table 3: Lifetime use of drugs among 15–16-year-olds in Ireland, ESPAD surveys 2003–2019









   












Trends over time suggest that current smoking 
among school-aged children in Ireland has 
stabilised and is greatly reduced since 2003, 
representing a 58% reduction (see Table 2).
When students were asked how difficult they 
thought it would be to access cigarettes, over 
one-third (38.2%) responded that it would be 
‘fairly easy’, while another 23.2% thought it 
would be ‘very easy’ to obtain a cigarette. Only 
5.5% responded that it would be ‘impossible’. 
Most students believed that there is a moderate 
risk (34%) or a slight risk (27.4%) of smoking 
occasionally, while 22.7% answered that they 
perceived a great risk from smoking one or more 
packs of cigarettes per day.
Other substance use
Students were asked how many times in their 
lifetime had they used cannabis. Male students 
(23.8%) were more likely than females (14.7%) 
to have ever tried cannabis. Overall, 19.1% of 
students had ever tried cannabis, of which most 
had tried it once or twice. There was also a 
sizeable minority of students who had smoked 
cannabis 20 times or more (4.1%).
Overall, 15.8% of students had used cannabis 
in the last 12 months. Again, more male (20%) 
than female respondents (11.8%) reported using 
cannabis in the past year. Almost 3.8% and 
2.4% of male and female students, respectively, 
reported using cannabis at least 20 times or 
more in the last year. Six per cent of males 
and 3.9% of females had first used cannabis at 
12 years or younger. Almost one-half (49.3%) 
of students first tried cannabis at 15 years of 
age and 11.4% first tried it at 13 years. When 
respondents were asked how easy they thought 
it would be to obtain cannabis, 46.3% perceived 
that it would be ‘impossible’, ‘very difficult’ or 
‘fairly difficult’, while 42.4% perceived that it 
would be ‘fairly easy’ or ‘very easy’.
Regarding lifetime use of other substances, after 
tobacco, alcohol, and cannabis, inhalants were 
the most commonly used substance at 10%. The 
next most regularly used drugs were painkillers 
‘to get high’ (5.4%), followed by cocaine, ecstasy, 
tranquilisers, magic mushrooms and LSD (3%) 
(see Table 3).
Trend analysis demonstrates that lifetime 
prevalence of cannabis use has remained 
relatively unchanged at approximately 20% since 
2007 among 15–16-year-olds in Ireland (see Table 
3). There has been a decrease in the use of illicit 
drugs other than cannabis by 29%, decreasing 
from 7% in 2015 to 5% in 2019. Overall, there has 
been a 69% reduction in the use of illicit drugs 
since 1995.
Conclusion
In summary, results from the ESPAD 2019 survey 
suggest a slight increase in the use of alcohol, 
while the use of cigarettes among school-
aged children in the Republic of Ireland has 
stabilised. The use of cannabis, inhalants, and 
other illicit substances may also have stabilised. 
Nevertheless, it should be noted that early 
school-leavers, a group known to be vulnerable 
to alcohol and drug use, are not represented in 
this survey. Consequently, the results may not 
indicate the true extent of alcohol and other 
illicit substance use among all 15–16-year-old 
children in Ireland.
Seán Millar
1 Sunday S, Keogan S, Hanafin J and Clancy L (2020) 
European Schools Project on Alcohol and Other 
Drugs: ESPAD 2019 Ireland. Dublin: TobaccoFree 
Research Institute Ireland and Department of 
Health. https://www.drugsandalcohol.ie/33347/
Seventh ESPAD survey report 
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Self-harm in Irish 
prisons, 2019
The Self-Harm Assessment and Data Analysis 
(SADA) Project was set up in Ireland in 2016 
to provide robust information relating to the 
incidence and profile of self-harm within 
prison settings as well as individual-specific and 
context-specific risk factors relating to self-
harm. In addition, it examines patterns of repeat 
self-harm (both non-fatal and fatal). The Health 
Service Executive’s National Office for Suicide 
Prevention and the National Suicide Research 
Foundation assist the Irish Prison Service with 
data management, data analysis, and reporting. 
This article highlights findings from a report 
presenting data in the analysis of all episodes of 
self-harm across the Irish prison estate during 
the year 2019.1
Episodes of self-harm
Between 1 January and 31 December 2019, there 
were 203 episodes of self-harm recorded in Irish 
prisons, involving 109 individuals. The majority of 
prisoners who engaged in self-harm were male 
(78%), but taking into account the male prison 
population, the rate of self-harm among males 
was 2.4 per 100 prisoners. Twenty-four female 
prisoners engaged in self-harm in 2019, equating 
to a rate of 19.8 per 100 prisoners, which is 8.2 
times higher than the rate among male prisoners.
Methods, severity, and intent
The most common method of self-harm 
recorded was self-cutting or scratching, which 
was present in 64.7% of all episodes. The other 
common method of self-harm was attempted 
hanging, which was involved in 21.1% of episodes. 
In 31% of self-harm episodes, no medical 
treatment was required, while almost one-
half (49.8%) of all episodes required minimal 
intervention/minor dressings or local wound 
management. One in seven episodes required 
hospital treatment (15.3%). Over two-thirds (69%) 
of self-harm episodes were recorded as having 
no or low suicidal intent, with 22% recorded 
as having medium intent. Approximately one in 
11 acts was rated as having high suicidal intent 
(8.9%).
Contributory factors
The most common contributory factors to 
self-harm are shown in Figure 1. The majority of 
contributory factors recorded related to mental 
health issues (44%). Substance misuse, including 
drug use and drug seeking, was the third most 
common factor recorded (19%).
Mental health issues





Relationship issues with signicant others
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 45.0 50.0
Percentage (%)
Figure 1: Most common contributory factors to self-harm in Irish prisons, 2019









   













infectious diseases  
in Ireland, 2020
The Health Protection Surveillance Centre 
(HPSC) is Ireland’s specialist agency for the 
surveillance of communicable diseases. Part of 
the Health Service Executive (HSE), and originally 
known as the National Disease Surveillance 
Centre, the HPSC endeavours to protect and 
improve the health of the Irish population by 
collating, interpreting, and disseminating data 
to provide the best possible information on 
infectious diseases. The HPSC has recorded new 
cases among injecting drug users of HIV since 
1982, HBV (hepatitis B virus) since 2004, and HCV 
(hepatitis C virus) since 2006. The figures and 
tables presented in this summary are based on 
data extracted from the Computerised Infectious 
Disease Reporting (CIDR) System in July 2021.1 
It should be noted that due to the Covid-19 
pandemic and related lockdowns, HIV, HBV, and 
HCV notification data for 2020 are incomplete. 
Consequentially, these data have not yet been 
extensively validated and should be considered 
provisional.
Main drug-related infectious diseases 
among people who use drugs – HIV, 
HBV, and HCV
HIV notifications, 2020
According to data compiled by the HPSC, at 
the end of 2020, some 449 people were newly 
diagnosed with HIV in Ireland, a notification 
rate of 9.4 per 100,000 population. This marks 
a decrease of 16% compared with 2019 (n=535) 
(see Figure 1).
Of the HIV notifications in 2020:
• 106 were male and 42 were female.
• 85 were men who have sex with men.
• For 67% (301) of the HIV notifications in 2020, 
there was no reported risk factor, although 
this is likely to change as more data become 
available.
In 2020, some eight HIV notifications were of 
people who inject drugs (PWID), compared with 
11 in 2019 (see Table 1). The figure for 2020 is the 
lowest number of PWID among HIV notifications 
since 2003 (see Figure 2).
Other findings
Other findings highlighted in the report include 
the following:
• Two-thirds (68%) of self-harm episodes 
involved prisoners in single cell 
accommodation. Considering the overall 
prison population, 51.9% of prisoners who 
self-harmed were accommodated in single 
cells in 2019.
• The rate of self-harm was higher among 
prisoners on remand or awaiting trial than 
among sentenced prisoners (5.7 vs 2.3 per  
100 prisoners).
• In line with findings from previous reports, 
substance misuse continues to be one of the 
primary factors associated with self-harm 
among the prison population in Ireland.
Seán Millar
1 McTernan N, Griffin E, Cully G, et al. (2021) Self- 
harm in Irish prisons 2019: third report from the 
Self-Harm Assessment and Data Analysis (SADA) 
Project. Longford: Irish Prison Service.  
https://www.drugsandalcohol.ie/34047/
Self-harm in Irish prisons, 2019   
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Figure 1: Number of new HIV notifications reported in Ireland, by year of notification, 2010–2020
Source: HSE and HPSC (2021)
Risk factor status Number (n) (%)
Total number of cases 449




Sex unknown 0 (0)
People who inject drugs 8 (5.4)
Men who have sex with men 85 (57.4)
Recipient blood/blood products 1 (0.7)
Other risk factors 54 (36.4)
No known risk factor identified 0 (0)
Cases without reported risk factor data 301
Table 1: New HIV notifications reported to the HPSC by risk factor status, 2020
Source: HSE and HPSC (2021)









   












Of the eight PWID among HIV notifications in 
2020, four were male and four were female, 
with a median age of 36 years. No subjects 
were under 25 years of age (see Table 2). 
The increased number of PWID among HIV 
notifications in 2014/15 was due to an outbreak 
of HIV among homeless people in Dublin 
who use drugs. The outbreak was declared 
over in February 2016. Key control measures 
implemented included raising awareness among 
clinicians, addiction services, and PWID; intensive 
case finding and contact tracing; early treatment 
of HIV infection in those most at risk; greater 
promotion of needle exchange; increased 
access to methadone treatment; frontline 
worker training; and raising awareness about safe 
injecting and safe sex. Leaflets were distributed 
in hostels and settings in Dublin where patients/
clients attended.
HBV notifications, 2020
There were 337 notifications of HBV in Ireland in 
2020, a decrease of 36% on 2019, when there were 
526 notifications. The notification rate for 2020 
was 7.1 per 100,000 population. HBV notifications 
halved between 2008 (n=897; 21.2/100,000 
population) and 2014 (n=442; 9.3/100,000 
population). Although provisional data on HBV 
notifications in 2020 are considerably lower than 
those reported in 2019, it should be noted that 
recent trends have suggested that the number of 
cases diagnosed and notified is stabilising rather 
than continuing to decline (see Figure 3).
Seventy-nine per cent (n=266) of the 337 HBV 
notifications in 2020 contained information on 
acute/chronic status. Of these, 96.2% (n=256) 
were chronically infected (long-term infection), 
while 3.8% (n=10) were acutely infected (recent 
infection). Risk factor data were available for eight 
of the acute cases notified in 2020. Of these acute 
cases, none was a person who injects drugs (see 
Table 3).
Drug-related infectious diseases in Ireland, 2020   continued
PWID actual number



















































































Figure 2: Number and rolling average number of PWID among HIV notifications reported in 
Ireland, by year of notification, 2003–2020
Source: HSE and HPSC (2021)
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Risk factor status Number (n) (%)











Dublin, Kildare or Wicklow 6
Table 2: Characteristics of new HIV notifications who reported injecting drug use as a risk factor, 
2020
Source: HSE and HPSC (2021)













2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
639 517 559 423 442 548 486 530 496 526 337HBV notications
Figure 3: Number of HBV notifications reported in Ireland, by year of notification, 2010–2020









   
























2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
1214 1234 874 751 690 672 639 607 589 474 326HCV notications
Figure 4: Number of HCV notifications reported in Ireland, by year of notification, 2010–2020
Source: HSE and HPSC (2021)
HBV status Acute Chronic Unknown 
Total number of cases 10 256 71
% of cases by status 3.0 76.0 21.1
Cases with reported risk factor 8 102 13
% of cases with risk factor data 80.0 39.8 18.3
Of which:
People who inject drugs 0 2 58
Cases without reported risk factor data 2 154 58
Table 3: Acute and chronic new HBV cases reported to the HPSC, 2020
Source: HSE and HPSC (2021)
Data excluding proxy risk factor of born in endemic country/asylum seeker.
Risk factor status Number (n) (%)
Total number of cases 326
Cases with reported risk factor data 153
Of which:
People who inject drugs 80 (52.3)
Recipient blood/blood products 6 (3.9)
Other risk factors 53 (34.6)
No known risk factor identified 14 (9.2)
Cases without reported risk factor data 173
Table 4: New HCV cases reported to the HPSC, by risk factor status, 2020
Source: HSE and HPSC (2021)
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Known injector cases Number (n) (%)








Under 25 years 7 (8.8)
25–34 years 18 (22.5)
Over 34 years 55 (68.8)
Age not known 0 (0)
Place of residence
Dublin, Kildare or Wicklow 46 (57.5)
Elsewhere in Ireland 34 (42.5)
Table 5: Characteristics of new HCV notifications who reported injecting drug use as a risk factor, 
2020
Source: HSE and HPSC (2021)
HCV notifications, 2020
There were 326 HCV notifications in Ireland in 
2020, a decrease of 31.2% on 2019, when there 
were 474 notifications. The notification rate for 
2020 was 6.8 per 100,000 population. There has 
been a downward trend in HCV notifications 
since peak numbers (n=1538) were recorded in 
2007. While provisional data on notifications from 
2020 suggest a continued decline (see Figure 
4), trends in notifications of HCV are difficult 
to interpret as acute and chronic infections 
are frequently asymptomatic, and most cases 
diagnosed and notified are identified as a result 
of screening in key risk groups. Therefore, 
notification patterns are highly influenced by 
testing practices, which may vary over time and 
may not reflect incidence very well.
Information on the most likely risk factor was 
available for 46.9% (n=153) of cases in 2020 
(see Table 4). Eighty cases with risk factor data 
were PWID and six were infected through 
contaminated blood products. No risk factors 
were identified for 14 cases, for whom risk factor 
data were available despite public health follow-
up.
The proportion of cases attributed to injecting 
drugs decreased from 88% in 2011 to 67% in 
2019, but risk factor data were not available for a 
significant number of cases. Hence, this finding 
is difficult to interpret. The number of cases that 
were PWID among provisional HCV notification 
data for 2020 is also likely to be a significant 
underestimate. Data for 2020 will improve as 
further validation work is carried out.
Of the PWID among HCV notifications in 2020, 
54 were male and 26 were female, with a median 
age of 40. Seven subjects were under 25 years 
of age. The majority (57.5%) resided in Dublin, 
Kildare or Wicklow (see Table 5).
Seán Millar
1 For further information on the CIDR System, visit: 
https://www.hpsc.ie/cidr/ 









   














services: a snapshot 
survey, 2021
Alcohol Action Ireland (AAI), the national 
independent advocate for reducing alcohol 
harm, surveyed a number of alcohol treatment 
service providers to explore issues around the 
provision of treatment services for harmful 
and dependent drinkers in Ireland. Its report,1 
published in 2021, forms part of AAI’s programme 
of work on its strategic goal to advocate for 
services for those affected by alcohol harm, as 
outlined in Leading change: a society free from 
alcohol harm. Strategic Plan 2020–2024.2
Introduction
There are an estimated 250,000 people with 
alcohol dependency problems in Ireland,3 
yet with a decrease in numbers accessing 
treatment.4 Using data from the National Drug 
Treatment Reporting System (NDTRS) of the 
Health Research Board (HRB), the report 
highlights there were approximately 7,500 
cases of treatment reported in 20194 and that 
the current national policy, Reducing Harm, 
Supporting Recovery,5 emphasises a health-led 
response to drug and alcohol use in Ireland, 
based on providing person-centred services that 
promote rehabilitation and recovery.
Methodology
Eleven residential rehabilitation services 
providing treatment interventions for harmful 
and dependent drinkers from a variety of 
locations were surveyed using a structured 
interview in early 2020. The service providers 
surveyed reported working with approximately 
2,000 people in 2019 and encompassed a 
range of treatment models – including the 
Minnesota model, the recovery model, and/or 
psychotherapeutic interventions – and a number 
of providers were trauma-informed.
Demographics
According to Health Service Executive (HSE) 
data, current provision of all addiction residential 
treatment beds (alcohol, drugs, and gambling) 
stands at 793 residential beds. These comprise:
• 19 inpatient unit detoxification beds
• 127 community-based residential 
detoxification beds
• 4 adolescent residential detoxification beds
• 625 residential rehabilitation beds
• 18 adolescent residential beds.
Over one-half of the service providers surveyed 
were funded through the HSE and services were 
free to the public. The remainder were private 
fee-paying services, the majority of which have 
beds funded through the HSE. Many service 
providers noted a change in demographics in 
recent years, principally the increasing number 
of young people coming into treatment and an 
increase in cocaine use. A number of service 
providers noted an increase in people coming 
to treatment via their workplaces or while 
continuing to work.
Themes
A number of issues in relation to the challenges 
facing alcohol treatment providers emerged from 
analysis of the interview transcripts. These were 
grouped into four themes:
• Mental health and trauma
• Reducing the impact on children and families
• Gaps in services
• Barriers to treatment.
For each theme, the report includes extracts 
from the interview transcripts to support the 
theme followed by AAI discussion and key 
recommendations, as follows.
Theme 1: Mental health and trauma
All service providers surveyed spoke of the 
significant and serious concern of dual diagnosis, 
where both alcohol addiction and a mental 
health problem co-occur. Yet this cohort very 
often experiences problems getting treated for 
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both issues in parallel. Service providers noted 
that those with a dual diagnosis require input 
from mental health professionals as part of their 
treatment and advocated for a shared approach 
to client’s mental health; however, additional 
funding for staff and/or training was required to 
do so.
Adverse childhood experiences (ACEs) such 
as abuse, neglect, loss, and other emotionally 
harmful traumatic experiences in childhood were 
acknowledged as an almost universal experience 
in the client population. Service providers held 
differing views on how best to address clients’ 
ACEs, with a number feeling that it is vital to 
understand their trauma in order to treat their 
addiction. However, others felt that unless there 
was a robust mechanism for dealing with that 
trauma, then ACEs should not be specifically 
raised.
Recommendations
• A national strategy with revised standards 
promoting best practice should be developed 
and implemented for residential services. 
Services should be person-centred and 
trauma-informed and monitored by the 
Health Information and Quality Authority 
(HIQA).
• Addiction services should have the skills 
and resources to respond to the mental 
health needs of their clients, suggesting a 
national training needs assessment, providing 
information on training already available 
through the HSE, and allowing staff time to 
take up training as required.
Theme 2: Reducing the impact on children 
and families
A number of service providers noted the 
intergenerational patterns which are frequently 
a feature of their clients, where members of the 
same family often experience similar substance 
misuse problems.
The effects of parental substance misuse have 
been largely hidden in Irish society; however, 
since 2019, a number of Irish studies, initiatives, 
and national policies have begun to recognise 
this hidden harm acknowledged as an ACE.5,6,7,8
Treatment services play an important role in 
identifying parents (particularly mothers and 
pregnant women) and providing interventions 
or pathways to reduce the harmful impact of 
addiction on children and to break the cycle 
of intergenerational substance abuse that is so 
often a feature of addiction. Developing and 
adopting family and parenting programmes 
for high-risk families impacted by problematic 
substance use are emphasised in the national 
drug and alcohol strategy.5
Recommendations
• Access to residential services for women with 
children should be improved. A coordinated 
approach between addiction services, 
maternity services, and children’s health and 
social care services to respond to the needs 
of children affected by parental substance 
misuse is required.
• In recognition of the impact of parental 
substance misuse, services should place 
greater emphasis on working with family 
members as clients in their own right rather 
than as adjuncts to the client presenting with 
the addiction.
Theme 3: Gaps in services
Service providers cited what they viewed as gaps 
in how treatment services are delivered. These 
included:
• Lack of access to detoxification services 
and the impact it has regarding access to 
treatment.
• Lack of aftercare support. A key element of 
recovery, including treatment and aftercare, is 
the assurance that an integrated approach will 
be taken and that people can move from one 
service to another as required.
Alcohol treatment services: a 









   












• Lack of staffing and resources. Service 
providers noted an issue around staffing levels 
and/or funding to provide the optimal service.
Recommendations
• Wider geographic access to addiction services 
should be provided, in accordance with 
the national drug and alcohol strategy, and 
diversifying the range of treatment options 
available to meet current and emerging needs 
should continue.
• There should be a national protocol on 
alcohol detoxification, streamlining the 
process of people moving straight from 
detoxification into residential treatment and 
aftercare services.
• A third-level course in specialist substance 
use should be developed and modules in 
substance misuse in counselling training 
courses should be included.
Theme 4: Barriers to treatment
As well as detoxification as a barrier to accessing 
treatment, other significant barriers quoted 
included the onerous admission criteria to 
residential care, the perceived stigma of going 
into treatment, and the financial costs limiting 
choice of treatment.
There was unanimity among service providers 
for greater recognition of the significant harm 
caused by alcohol. However, the funding, 
services, and policy interventions required 
are inadequate to deal with the scale of the 
problems presenting.
The prevalence of faith-based service providers 
was highlighted by a number of the participating 
service providers.
Recommendations
• The Government should acknowledge the 
harms caused by alcohol to individuals, their 
families, and to society and should fund 
services appropriately.
• An oversight body for all treatment service 
providers should be established, with 
comprehensive standards, regulation, and 
inspection to ensure that faith-based services 
meet the requirements of a modern human-
rights-based service.
Conclusion
The high socioeconomic costs of alcohol harm 
in Ireland include costs to the healthcare system, 
criminal justice system, lost work, and loss of 
life. According to the World Health Organization, 
services ‘should be sufficiently strengthened and 
funded in a way that is commensurate with the 
magnitude of the public health problems caused 
by harmful use of alcohol’.9
It is important to understand the kinds of 
treatment services provided, the costs of 
services, and the outcomes and effectiveness of 
services in order to have a clear view of what is 
required to ensure modern and effective service 
provision. The current drug and alcohol strategy 
has adopted a health-led approach to addiction; 
however, alcohol treatment services do not fall 
under HIQA’s national guidance like other health 
services.
A national strategy for residential services and 
a HIQA inspection regime would ensure that 
Ireland’s treatment services are equipped to 
provide the best possible care to people in need.
Anne Doyle
1 Alcohol Action Ireland (2021) Alcohol treatment 
services: a snapshot survey 2021. Dublin: Alcohol 
Action Ireland.  
https://www.drugsandalcohol.ie/34359/
2 Alcohol Action Ireland (2019) Leading change: a 
society free from alcohol harm. Strategic Plan 
2020–2024. Dublin: Alcohol Action Ireland.  
https://www.drugsandalcohol.ie/31321/
3 O’Dwyer C, Mongan D, Doyle A and Galvin B (2021) 
Alcohol consumption, alcohol-related harm and 
alcohol policy in Ireland. HRB Overview Series 11. 
Dublin: Health Research Board.  
https://www.drugsandalcohol.ie/34058/
4 Condron I, Carew AM and Lyons S (2020) National 
Drug Treatment Reporting System 2013–2019 
alcohol data. Dublin: Health Research Board. 
https://www.drugsandalcohol.ie/32093/
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9 World Health Organization (WHO) (2019) 10 areas 
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Targeted Response with Youth (TRY) is a peer-
mentoring project based in Dublin's south inner 
city, which targets young people involved in or at 
risk of becoming involved in the drug economy 
and antisocial behaviour (ASB). An evaluation 
of the programme was published in November 
2020, entitled Relentless caring: trying something 
new.1
Meeting a need
The project is based in and around St Teresa’s 
Gardens (STG), a local authority complex in 
Dublin’s south inner city. The area has high levels 
of early school leaving, unemployment, poor 
mental and physical health outcomes, crime, and 
drug use. Under the Pobal HP Deprivation Index, 
it was categorised as ‘very disadvantaged’, the 
lowest score on the scale.2 Ongoing regeneration 
of the STG complex has meant that many tenants 
were moved elsewhere, leaving residences 
empty to facilitate new builds. The report 
argues that ‘as a consequence of detenanting 
STG, a small group of marginalised, hostile and 
“extremely threatening” young men with external 
addresses but family ties in STG made it their 
daily stomping ground for ASB and drug-related 
activity, negatively impacting the quality of life 
of residents’ (p. 16). Recourse to control tactics, 
such as prosecution and imprisonment or the 
threat of eviction for those living elsewhere, 
had failed to address the community’s needs. In 
addition, the young people causing the problems 
were considered hard to reach. A stakeholder 
described them as ‘extremely marginalised 
people who are not liked in the community and 
people do not want to work with them’ (p. 27). 
The lack of appropriate services to address the 
complex needs of these young people, and the 
consequences of their behaviour, led to the 
establishment of TRY.
Delivery model
Based on the experiences of national and 
international projects, TRY uses the intensive 
outreach and bridging (IOB) model.3 Youth 
workers contact the targeted young people at 
street level, build trust, and provide them with 
emotional and practical support. There is a 
focus on building their self-esteem and other 
positive traits to enable them to extend their 
social networks beyond those associated with 
the drugs economy. In addition, the project 









   












engage with services, depending on their needs. 
Services accessed include those related to 
education or work pathways, physical or mental 
health services, housing, and childcare facilities. 
Engagement takes place on a one-to-one basis 
and through group work.
Target group
When it started in 2017, the project targeted a 
group of young men (aged 18–24 years) who were 
engaged in ASB, including drug-related activity, 
in and around STG. The project subsequently 
expanded to include young women and those 
under the age of 18. Between October 2019 and 
September 2020, TRY worked with 37 young 
people: 22 males (aged 18–24), 13 females (aged 
18–24), and two under-18s (aged 14–17) (p. 41).
Method of evaluation
The evaluation involved a literature review, 
documentary analysis, and qualitative 
interviews with a variety of stakeholders (n=19). 
Participants were mainly those involved in the 
delivery and governance of the project. Only 
two local residents and two TRY participants 
were interviewed. Interviews were recorded 
and thematic analysis carried out on the data. 
No additional detail on the sampling, fieldwork 




Young people participating in the project 
tended to have experienced one or more of a 
wide range of childhood adversities, including 
domestic, physical, and emotional abuse; 
familial drug addiction; parental incarceration; 
community violence; and family bereavements. 
It was identified as a ‘major problem’ (p. 28) that 
these traumas were often not discussed, which 
stakeholders described as leading to much anger 
among the young people. This was thought to 
have contributed to other service providers 
finding them challenging, hard to reach, and 
difficult to engage.
Central role of mentor relationship
Central to the success of the project is the 
relationship that mentors develop with the 
young people. A high level of trust must be 
built between the two, which takes time 
and persistence on the part of the mentor. 
The author argues that the mentor must be 
‘authentic, believable, caring and kind’ (p. 
24) with the relationship being built through 
intensive outreach. There also needs to be 
‘exceptional levels of professionalism [on the 
part of the mentor] to appear to be involved 
in casual conversation but to actually have a 
careful professional agenda’ (p. 31), through 
which the young person’s needs are identified 
and bridging to appropriate services takes 
place. Staff also need a high degree of flexibility 
to deliver interventions at locations and times 
required by the young people. It was deemed 
critical that mentors have similar life experiences 
to participants and come from the same type of 
background.
Structured assessment
Mentors use various tools to add structure to 
how they work with young people. For example, 
they use a goals scale to highlight the gaps in a 
beneficiary’s life and to help them visualise and 
set achievable goals. They also use a logic model 
to determine what referrals need to be made 
and to support their bridging role.
Bridging
As the relationship between the mentor and 
young person develops, new needs frequently 
emerge. Additional needs often relate to mental 
health, parenting skills, anger management, 
and a desire to access addiction treatment 
services. Close collaboration between mentors 
and other service providers to meet the young 
people’s needs is critical. Mentors act as a bridge 
between the two and provide ongoing support to 
the young people to maintain attendance. This 
includes attending appointments with the young 
person.
Evaluation of Targeted Response 
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From October 2019 to September 2020, the total 
number of contacts made with individuals was 
1,552 (p. 27), where the breakdown of referrals 
made to services in 2020 was: 22% to education/
training; 24% drug intervention; 7% housing; 
19% employment; 9% social welfare/money; and 
health services 19% (p. 36). The report includes 
examples of young people’s confidence building 
and of taking up opportunities to further their 
education, enter employment, and access other 
services to meet their health needs. Table 1 
summarises the outcomes reported by the 
project for 2019/20.
Cost effectiveness
While no value-for-money analysis was carried 
out, the author does compare the costs of TRY 
(approximately €100,000 in 2019) with those of 
punitive criminal justice responses. The cost 
of detaining one young person in Oberstown 
Children Detention Campus is €383,574 and of 
imprisoning an adult is €75,349. She concludes 
that ‘in terms of criminal justice savings alone, 
the TRY project since its inception [2017] has 
been very good value indeed’ (p. 23).
Concluding comment
The findings echo those of an earlier more 
comprehensive piece of work published in 2019 
by Bowden, notably The drug economy and 
youth interventions: an exploratory research 
project on working with young people involved 
in the illegal drugs trade.4,5 While the TRY 
evaluation provides useful insights into the TRY 
project and the value of mentoring for this 
cohort of young people, it is also limited. A key 
limitation is that only two project participants 
took part. It is important that young people’s 
voices are heard in evaluations of programmes 
that affect them. Without this, there can only 
be a limited assessment of the strengths and 
weaknesses of a programme as regards for whom 
it works well and why. However, the key messages 
from Bowden’s report4,5 remain relevant here:
• Engaging with people who are involved in 
drug distribution is not about excusing their 
behaviour, rather understanding it with the 
aim of prevention.
• Any engagement needs to be structured 
around a strong relationship with an advocate, 
characterised by trust and understanding.
• Young people involved in the drug economy 
or at risk of getting involved are reachable. 
If there were viable educational and 
employment pathways open to them, many 
would desist from the drug economy.
Lucy Dillon
1 Mulcahy J (2020) Relentless caring: trying something 
new. An evaluation of the Targeted Response with 
Youth TRY project. Dublin: Donore Community Drug 
and Alcohol Team.  
https://www.drugsandalcohol.ie/34556/ 
2 The Pobal HP Deprivation Index shows the degree 
of overall affluence and deprivation at the level of 
electoral division using data compiled from the Irish 
Census.
Evaluation of Targeted Response with Youth   continued
Group Training Education Employment Health Drug services Total participants
Men 10 10 5 8 11 22
Women 4 3 2 2 2 13
Under-18s 1 1 2
Total outcomes 15 13 8 10 13 -
Table 1: TRY project outcomes October 2019–September 2020 (Sláintecare Integration Fund 
interim report)









   












3 National and international IOB projects include 
the Easy Street project of Ballymun Regional Youth 
Resource (BRYR), Dublin and the Lugna Gatan (Easy 




4 Bowden M (2019) The drug economy and youth 
interventions: an exploratory research project on 
working with young people involved in the illegal drugs 
trade. Dublin: CityWide Drugs Crisis Campaign.  
https://www.drugsandalcohol.ie/30487/ 
5 Dillon L (2019) The drug economy and youth 
interventions. Drugnet Ireland, 70 (Summer): 12–14. 
https://www.drugsandalcohol.ie/31007/ 
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A long-brewing crisis: the historical antecedents 
of major alcohol policy change in Ireland
Lesch M and McCambridge J (2021) Drug and 
Alcohol Review, Early online. 
https://www.drugsandalcohol.ie/34383/ 
Using policy feedback theory, this study specifically 
investigates the political consequences of 
accumulating alcohol-related health and social 
harms for processes of policy change prior to 
2009.
Not acting on the population health harms caused 
by alcohol can produce significant societal costs, 
particularly when consumption is rising, and entail 
subsequent political consequences. Understanding 
of innovations in alcohol policy decision making 
requires an appreciation of the historical context, 
including earlier policy failures.
National Drugs Library
Waiting for the wave: political leadership, policy 
windows, and alcohol policy change in Ireland
Lesch M and McCambridge J (2021) Social Science 
& Medicine, 282: 114116. 
https://www.drugsandalcohol.ie/34443/ 
Ireland’s 2018 alcohol legislation adopts key 
evidence-based measures, introducing pricing, 
availability and marketing regulations that are 
world-leading in public health terms. Drawing 
primarily on the Multiple Streams Approach (MSA), 
this study investigates the adoption of the Public 
Health (Alcohol) Act 2018. We draw data from 
20 semi-structured interviews with politicians, 
government advisors, public health experts, 
and advocates, as well as from relevant primary 
documents, newspaper articles, and other material 
in the public domain. 
We find that increased public attention to alcohol-
related harms in Ireland (problem stream), 
developments within the institutional location of 
policymaking (the policy stream), and the political 
pressure exerted by politicians and advocates (the 
political stream) all combined to open a policy 
window. Unlike previous alcohol policy reform 
efforts in Ireland, several personally committed 
and well-positioned leaders championed policy 
change. This study suggests that political leadership 
might be important in understanding why public 
health approaches to alcohol have been embraced 









   













The Five Nations model for prison health 
surveillance: lessons from practice across the UK 
and Republic of Ireland
Perrett S, Plugge E, Conaglen P, O’Moore E and 
Sturup-Toft S (2020) Journal of Public Health,  
42(4): e561-e572. 
https://www.drugsandalcohol.ie/34235/ 
Prison populations experience an increased 
burden of physical, mental and social health needs 
compared to the community, further impacted by 
the prison environment. Surveillance systems to 
monitor health and well-being trends in prisons are 
lacking, presenting a challenge to services planners, 
and policy makers who often lack evidence to 
inform decisions.
The Five Nations Health and Justice Collaboration 
is proposing a new model for prison health 
surveillance, based on established guidelines 
for public health surveillance but with additional 
features that recognize the uniqueness of the 
prison environment and need for a whole prison 
approach, built on collaboration and sharing of 
data between health and justice sectors.
The impact of guidance on the supply of 
codeine-containing products on their use in 
intentional drug overdose
Birchall E, Perry IJ, Corcoran P, Daly C and Griffin 
E (2021) European Journal of Public Health, 31(4): 
853–858. 
https://www.drugsandalcohol.ie/34300/ 
The aim of this study was to examine the impact 
of this guidance [restricting the supply of over-
the-counter (OTC) codeine-containing products] 
on the national rate of hospital-presenting self-
harm involving codeine-related intentional drug 
overdose (IDO).
Our findings indicate that the rate of codeine-
related IDOs was significantly lower in the period 
following the implementation of the guidance. 
There is a large body of evidence supporting the 
restriction of potentially harmful medication as an 
effective strategy in suicide prevention.
Recent publications   continued PREVALENCE AND CURRENT SITUATION
‘They don't actually join the dots’: an exploration 
of organizational change in Irish opiate 
community treatment services
Peter K, Hegarty J, Dyer Kyle R and O’Donovan A 
(2021) Journal of Substance Abuse Treatment,  
Early online, p. 108557. 
https://www.drugsandalcohol.ie/34598/ 
This study was conducted across Irish community 
opiate prescribing services and drew on data from 
12 in-depth qualitative interviews with frontline 
staff. This paper examines the narratives of staff 
about the factors which influence the dynamics 
and process of treatment services, particularly in 
relation to the implantation of change.
A range of interdependent factors which influence 
an ‘eco-system’ of service delivery were identified. 
Effective policy implementation in Ireland remains 
aspirational, but findings reported in this paper 
have important implications for future planning and 
design of services for people who use drugs, and 
provide a good basis for further investigation.
53
Issue 79  |  Autum
n 2021     drugnet Ireland      
A cross-section observational study on the 
seroprevalence of antibodies to COVID-19 in 
patients receiving opiate agonist treatment
Fenton F, Stokes S and Eagleton M (2021) Irish 
Journal of Medical Science, Early online. 
https://www.drugsandalcohol.ie/34581/ 
This study was conducted to determine 
seropositivity to the COVID-19 virus in patients 
attending the HSE National Drug Treatment Centre 
(NDTC), and to establish if patients tested had any 
clinical symptoms of this disease since March 2020.
Findings indicate (a) possible low level of exposure 
to COVID-19 among this patient cohort or (b) that 
those patients who have been exposed have not 
developed or maintained detectable antibody 
levels, nor developed symptoms of the disease. 
Public health measures could explain the low level 
of COVID-19 in this cohort. The findings are also 
consistent with the possibility of a protective effect 
of OAT [opiate agonist treatment] medications on 
development of the disease.
Online news media reporting of ketamine as a 
treatment for depression from 2000 to 2017
Gallagher B, Neiman A, Slattery M-C and 
McLoughlin DM (2021) Irish Journal of  
Psychological Medicine, Early online, pp. 1-9. 
https://www.drugsandalcohol.ie/34513/ 
Our objective was to examine how online 
news outlets have portrayed ketamine as an 
antidepressant by ascertaining the volume and 
content of relevant articles and trends over time. 
Online news media articles have been generally 
positive about ketamine for treating depression 
but need to be interpreted with caution as many of 
them did not discuss negative aspects of ketamine 
and made unsubstantiated claims about ketamine.
Recent publications   continued College students’ perspectives on an alcohol 
prevention programme and student drinking  
– a focus group study
Calnan S and Davoren MP (2021) Nordic Studies  
on Alcohol and Drugs, Early online. 
https://www.drugsandalcohol.ie/34130/ 
This qualitative study aimed to address this gap 
[limited research on students’ own perspectives on 
alcohol and related harms reduction interventions] 
by examining college students’ perspectives in the 
context of an alcohol prevention programme for 
college students in Ireland.
Viewing the findings through a social-ecological 
lens, students seemed to collectively acknowledge 
the different layers of influence on student 
drinking, acknowledging the complex nature of this 
issue. Providing a greater variety of leisure spaces, 
including alcohol-free environments, was viewed 
particularly favourably by the student participants 









   












Association between electronic cigarette  
use and tobacco cigarette smoking initiation in 
adolescents: a systematic review and  
meta-analysis
O’Brien D, Long J, Quigley J, Lee C, McCarthy A and 
Kavanagh P (2021) BMC Public Health, 21(1): 954. 
https://www.drugsandalcohol.ie/34317/ 
This systematic review of prospective longitudinal 
primary studies sought to determine whether 
electronic cigarette (e-cigarette) use by teenagers 
who had never smoked conventional tobacco 
cigarettes (tobacco cigarettes) at baseline was 
associated with subsequently commencing tobacco 
cigarette smoking.
The systematic review found that e-cigarette use 
was associated with commencement of tobacco 
cigarette smoking among teenagers in Europe and 
North America, identifying an important health-
related harm. Given the availability and usage of 
e-cigarettes, this study provides added support 
for urgent response by policymakers to stop their 
use by teenagers to decrease direct harms in 
this susceptible population group, as well as to 
conserve achievements in diminishing tobacco 
cigarette initiation.
Recent publications   continued From heavy cannabis use to psychosis: is it time 
to take action?
Johnson-Ferguson L and Di Forti M (2021) Irish 
Journal of Psychological Medicine, Early online, 
pp. 1-6. 
https://www.drugsandalcohol.ie/34271/
In this editorial, we first present and critically 
discuss the evidence to date of the association 
between heavy cannabis use and psychosis. 
We argue that while the biological mechanisms 
underlying individual susceptibility to develop a 
psychotic disorder following heavy cannabis use 
are still unknown, heavy cannabis use remains 
the most modifiable risk factor for the onset 
of psychotic disorders and for its clinical and 
functional outcome. This demands a clear move 
towards both primary and secondary prevention 
intervention to reduce the impact of heavy 
cannabis use on the incidence and prevalence of 
psychotic disorders.
Common mental disorders among Irish jockeys: 
prevalence and risk factors
King L, Cullen SJ, O’Connor S, McGoldrick A, Pugh 
J, Warrington G, Woods G, Nevill AM and Losty C 
(2021) The Physician and Sportsmedicine, 49(2): 
207–213.  
https://www.drugsandalcohol.ie/34216/ 
The aim of the present study was to further 
explore the prevalence of CMDs [common 
mental disorders] among jockeys and to test for 
associations with potential risk factors.
The findings indicate that jockeys report CMD 
symptoms at comparable rates to athletes in other 
sports. The study was the first to highlight potential 
risk factors as predictors of CMDs among jockeys, 
including burnout, career satisfaction, and the 
current contemplation of retirement. Screening 
tools for the risk factors demonstrated may, 
therefore, provide useful in the early identification 
of CMDs among jockeys. The development of 
jockey-specific assessment tools, education 
programmes, and interventions may help better 
understand and support the mental health of 
jockeys.
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‘Special death’: living with bereavement by drug-
related death in Ireland
Lambert S, O’Callaghan D and Frost N (2021)  
Death Studies, Early online, pp. 1-11. 
https://www.drugsandalcohol.ie/34409/ 
This paper explores the impact of complicated 
grief on the family system following the drug-
related death of a family member. Drug-related 
deaths are rife with moral stigmas, and those left 
behind often carry an emotional burden laden 
with shame and guilt. Seventeen bereaved family 
members were interviewed using semi-structured 
interviews and transcripts were analyzed using 
reflexive thematic analysis. Three core themes 
were generated: Renegotiation of Relationships; 
Experiencing Complex Emotions; and Adjusting to  
a New Reality. 
The findings demonstrate that this population 
experiences great difficulty in processing their grief 
as they struggle with family breakdown, navigating 
supports and stigma.
A decade of DOVE: multidisciplinary experience 
from an obstetrics addiction clinic
Eogan M, Gleeson J, Ferguson W, Jackson V, 
Lawless M and Cleary B (2021) Irish Medical 
Journal, 114(5): 352. 
https://www.drugsandalcohol.ie/34286/ 
The aim of this study was to review a decade of 
attendances at an addiction obstetrics clinic and 
compare with the general hospital population.
This limited retrospective review of women with 
addiction in pregnancy identifies a changing profile 
of attendances. It acknowledges the important role 
of the drug liaison midwife. It highlights increased 
risks for this population regarding prematurity 
and growth restriction, and it is important that 
these are reflected in care pathways and patient 
education. Further prospective multivariate 
analysis is advised to drive responsive service 
planning to optimise care of pregnant women  
with addiction.
Recent publications   continued Patterns of new psychoactive substance use 
among opioid-dependent patients attending for 
opioid substitution treatment
McCarron P, Smyth BP, Carroll G, Glynn M, Barry J, 
Whiston L, Keenan E, Darker CD and Truszkowska 
E (2021) Heroin Addiction and Related Clinical 
Problems, Early online. 
https://www.drugsandalcohol.ie/34176/ 
Among patients attending an opioid substitution 
clinic we sought to investigate reasons for NPS 
[new psychoactive substances] use, administration, 
adverse effects, and consumption in the previous 
three months.
In the current study the majority of those who 
had ever taken NPS did so before 2010 (when 
legislation forced the closure of headshops), and 
only 11% of participants reported ongoing NPS use, 
suggesting that making the supply of NPS illegal 
reduced their consumption. Furthermore, since a 
high proportion of participants administered NPS 
intravenously, the closure of headshops is likely to 
have led to improved health outcomes among this 
group of patients.
Doctor-patient interactions that exclude 
patients experiencing homelessness from health 
services: an ethnographic exploration
O’Carroll A and Wainwright D (2021) BJGP Open, 
5(3): BJGPO.2021.0031. 
https://www.drugsandalcohol.ie/34189/ 
This research sought to explore barriers to 
health service usage for people experiencing 
homelessness.
There are certain recurrent interactions between 
people experiencing homelessness and doctors 
that result in the exclusion of people experiencing 









   












A qualitative study of the perceptions of mental 
health among the Traveller community in Ireland
Villani J and Barry MM (2021) Health Promotion 
International, 36(5): 1450–1462. 
https://www.drugsandalcohol.ie/33798/ 
This study explores Travellers’ perceptions of 
mental health and its determinants. It also identifies 
the most relevant factors for promoting positive 
mental health and wellbeing among this socially 
excluded group.
The findings suggest that Travellers’ mental health 
is multidimensional and requires a socio-ecological 
approach that addresses the wider determinants 
of health. Community mental health promotion 
initiatives should focus on reducing discrimination, 
enhancing social and emotional wellbeing and 
self-esteem, improvement of living conditions, 
reduced mental health stigma, and the promotion 
of Traveller culture and positive self-identity.
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Markedly poor physical functioning status of 
people experiencing homelessness admitted to 
an acute hospital setting
Kiernan S, Ní Cheallaigh C, Murphy N, Dowds J and 
Broderick J (2021) Scientific Reports, 11: 9911. 
https://www.drugsandalcohol.ie/34166/ 
The objective of this study was to evaluate a broad 
range of physical functioning variables to enable 
better future planning of targeted health and 
accommodation services for this group [homeless 
adults].
This study revealed hospital in-patients registered 
as homeless displayed particularly poor physical 
functioning levels and mobility regardless of age. 
Health and housing services should address the 
unmet physical functioning needs of this vulnerable 
group.
